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Pluripotent stem cells have an enormous potential to self-renew indefinitely and 
differentiate into ectoderm, mesoderm and endoderm, the three germ layers of the 
body. This striking ability has turned PSCs throughout the years to be a major driver 
of regenerative medicine research and applications that utilize such cells for 
generation of cell types of interest thereby including disease modeling, drug 
screening and cell replacement-based therapies. However, creating PSC-based 
differentiation platforms that ensure derivation of homogenous cultures for desired 
clinically relevant cell types is critical for meaningful understanding and usage of 
such cells for therapy. Currently, cell heterogeneity is still one of the major hurdles 
for cell replacement-based therapy even following decades of stem cell research. 
Therefore one of the major goals of the field is to develop strategies for generating 
homogenous cell types from PSCs. 
 
Our lab is mainly interested in studying PSC-based central nervous system (CNS) 
development, with particular focus on the development of the cerebral cortex. The 
cerebral cortex (or neocortex) is the newly evolved and most complex structure of 
human brain, which is the site for higher order functions such as sensory perception, 
cognition and emotions. Methods for deriving cortical progenitors from PSCs are 
highly diverse and largely lack robust readouts, and hence are prone to yield 
heterogeneous populations that contain both cortical and non-cortical CNS cell types 
among other non-neural cell types. Combining knowledge from in vivo cortical 
developmental studies and previous findings from our lab on in vitro studies of neural 
differentiation from PSCs, in this study we show a streamlined strategy to generate 
homogenous cortical progenitors from PSCs by inhibiting WNT pathway on top of 
routinely used dual SMAD inhibition. We perform a systematic comprehensive 
comparison, at both molecular and cellular levels, of previously the major known 
cortical differentiation paradigms side by side with our combined WNT and dual 





We employ bulk RNA-Sequencing and analysis of 10,000 differentially expressed 
genes among single organoids and human brain samples to reveal that combined 
WNT and dual SMAD inhibition exclusively reproduces neocortical fates, dual SMAD 
inhibition induces diencephalic-mid-hindbrain fates, and inhibition-free conditions 
promote mixed fates. Further employing Single cell RNA-Sequencing we confirm the 
brain regional heterogeneity observed in bulk RNA-Seq, highlighting enriched 
cortical stem cell population in organoids derived under combined WNT and dual 
SMAD inhibition. On the other hand, we find that dual SMAD-i and inhibitor-free 
organoids are heterogeneous consisting of both cortical and non-cortical 
populations. Single cell RNA-Sequencing also confirm the presence of the major 
cortical cell types including neural stem cells, intermediate progenitors and neurons 
in organoids derived by both dual SMAD-i and Triple-i. 
 
In this study we also revisit the role of radial organization (rosette formation) – 
conventionally known to mark general neural fate conversion - and assign it as 
unique feature of cortical NSCs. We particularly show that enhanced Notch 
activation (stemness) and efficient radial organization are integral and overlapping 
hallmarks of homogeneous neocortical specification. We also show that this feature 
is dramatically streamlined under Triple-i in both 2D (rosettes) and 3D (organoids) 
systems, thus functionally linking stemness, cell polarity and the robust acquisition of 
cortical fates under combined inhibition. In support to this finding, inhibitor-free 
cultures exhibit weak Notch activation not necessarily overlapping radial 
organization, while SMAD cultures show Notch activation in non-radially organized 
regions enriched for non-cortical fates. We therefore propose these features – when 
overlapping – could be used as reliable readouts for efficient cortical differentiation. 
 
As a proof of concept for the utility of our findings for regenerative medical research 
and applications, we use brain organoid technology as platform to model 
neurodevelopmental disorders such as microcephaly. Microcephaly is a genetically 
heterogeneous cortical developmental disorder characterized by abnormalities in the 
development of the cortex resulting in smaller brain size. We derive microcephaly 
organoids by generating hESCs harboring defects in the centrosomal protein STIL, 
and show that such organoids display apoptosis within Notch active and radially 
organized vesicles, arrest in cell cycle, premature differentiation and loss of cortex 
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specific marker expression only when derived by combined WNT and dual SMAD 
inhibition, demonstrating cortex-specific etiology. Thus, combined WNT and dual 
SMAD inhibition is indispensable for standardized modeling of corticogenesis in 
health and disease. 
 
Abstract (Deutsch) 
Pluripotente Stammzellen (PSCs) haben ein enormes Potential zur unbegrentzen 
Selbsterneuerung und Differenzierung zu den drei Keimschichten des Körpers: 
ektoderm, mesoderm und endoderm.  Diese auffällige Kapazität hat dazu geführt, 
dass PSCs eine wichtige Rolle in der regenerativen Medizinforschung spielen.  Ihr 
Potential, verschiedene Zellenarten zu generieren, ermöglicht ihre Verwendung in 
vielen Bereichen, zum Beispiel Krankheitsmodellierung, Drogenscreening und 
Zellensubstitutionstherapien. Um die PSCs erfolgreich für diese Therapien 
anzuwenden, braucht man Differenzierungsplatformen, die Herleitung homogener 
Zellkulturen für klinisch relevante Zellenarten sicherstellen.  Auch nach Jahrzehnten 
der Stammzellforschung ist die Zellenheterogenität derzeit eine der größten Hürden 
für Zellensubstitutionstherapien.  Deshalb ist eins der größten Ziele dieses 
Forschungbereichs Strategien für die Generierung homogener Zellenarten aus PSCs 
zu entwickeln. 
 
Unser Labor interessiert sich hauptsächlich dafür, die Herstellung vom 
Zentralnervensystem (ZNS), besonders von der Großhirnrinde, von pluripotenten 
Stammzellen zu studieren.  Die Großhirnrinde (der Neocortex) ist die neuentwickelte 
und komplizierteste Struktur des Menschengehirns, das für Funktionen höherer 
Schichten, z.B. die Sinneswahrnehmung, Kognition, und Emotion, verantwortlich 
ist.  Die Methoden, die zurzeit für die Herstellung von Kortikalprogenitorzellen 
angewendet werden, sind sehr vielfältig und haben einen Mangel an robusten 
Auslesungen.  Deswegen haben diese Methoden das Problem, dass sie heterogene 
Populationen von kortischen und nicht kortischen Zellenarten des ZNS und dazu 
nicht neurale Zellenarten herstellen.  Durch die Kombination des Wissens von in 
vivo Studien über die kortische Entwicklung und vorherigen in vitro Ergebnissen 
unseres Labors über Neuraldifferenzierung von PSCs, zeigen wir in dieser Studie 
eine stromlinienförmige Strategie.  Diese Strategie erschafft homogene 
Kortikalprogenitorzellen von PSCs durch die Inhibition von dem WNT Signalweg und 
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die routinemäßig benutzten dual SMAD Inhibition (Triple-i).  Wir führen einen 
systematisch umfassenden Vergleich in molekularen und zellularen Ebenen 
durch.  Wir vergleichen die bisherigen Methoden, die für den kortischen 
Differenzierungsprozess angewendet sind, mit unserer Triple-i Methode in 2D 
Monoschichten und 3D organoidzüchtungplatformen. 
 
Wir benutzen bulk RNA Sequenzieren und die Analyse von 10.000 differentiell 
exprimierten Genen zwischen organoids und Proben von Menschengehirnen. Wir 
stellen fest, dass die Kombination der Inhibition von dem WNT Signalweg und dual 
SMAD Inhibition das neokortische Zellschicksal ausschließlich erschafft.  Wir zeigen 
auch, dass die dual SMAD Inhibition diencephalic-mid-hindbrain Zellschicksalen 
ermöglicht und dass keine Inhibition gemischte Zellschicksale fördert.  *Weiterhin 
bestätigen wir mit der Einstellung Einzel-Zell RNA Sequenzieren (single cell RNA-
Sequencing) die regionale Heterogenität zwischen organoid Entwicklungsmethoden, 
die wir in bulk RNA-Seq gesehen haben.  Durch die Analyse von scRNA-Seq Daten 
von Gehirnorganoids finden wir dazu eine hochangereichte kortische 
Stammzellpopulation in Triple-i organoids.  Wir finden aber auch, dass dual SMAD-i 
organoids und organoids unter keiner Inhibition mehr heterogen sind.  Diese 
organoids enthalten kortische und nicht kortische Zellpopulationen.  Single cell RNA-
Sequencing bestätigt die Anwesenheit wichtiger kortischer Zellenarten inklusive 
Nervenstammzellen, Kortikalprogenitorzellen und Nervenzellen in dual SMAD-i und 
Triple-i organoids. 
 
In dieser Studie untersuchen wir u.a. die Rolle von der radialen Organisation 
(Rosettebildung), die eine wichtige Rolle in dem Nervenzellschicksal spielt.  Diese 
Organisation wird dann als einzigartige Eigenschaft den kortischen 
Nervenstammzellen zugewiesen.  Insbesondere zeigen wir die integrale Rolle von 
vergrößerter Notch Aktivierung für effiziente radiale Organisation.  Diese beiden 
Charakterisierungen sind Eigenschaften für die homogene neokortische 
Spezifizierung.  Wir zeigen zudem, dass diese Eigenschaft in 2D (Rosetten) und 3D 
(organoids) Systemen, die mit der Triple-i Methode entwickelt worden, dramatisch 
stromlinienförmig gemacht wird.  Dadurch verbinden wir Stammzelleigenschaften mit 
Zellpolarität in der kortischen Zellschicksalprozess unter Triple-i.  Um diese 
Ergebnisse zu unterstützen, finden wir eine schwache notch Aktivierung und ihre 
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Überschneidung mit radialer organistation in Systemen, die mit keiner Inhibition 
entwickelt worden.  Dazu finden wir eine hohe notch Aktivierung in nicht radial 
organisierten Regionen, die nicht kortische Zellschicksale in Zellkulturen anreichern, 
die mit dual SMAD Inhibition entwickelt worden.  Deswegen schlagen wir Folgendes 
vor: wenn diese Eigenschaften in Überschneidung zu sehen sind, können sie als 
eine zuverlässige Auslesung für eine effiziente kortische Differenzierung gelten. 
Um diesen Konzeptnachweis zu veranschaulichen, besonders im Forschungsgebiet 
der regenerativen Medizinforschung und ihrer Anwendungen, benutzten wir die 
Gehirnorganoidtechnologie als platform, neural Entwicklungsstörungen zu 
modellieren, insbesondere Mikrozephalie.  Mikrozephalie ist eine genetisch 
heterogene kortische Entwicklungsstörung, die durch Abnormitäten im kortischen 
Entwicklungsprozess gekennzeichnet ist und zu einer kleineren Gehirngröße 
führt.  Wir entwickeln mikrozephalische organoids von embryonischen Stammzellen 
von Menschen (hESCs) mit einer mutation im zentrosomischen Protein STIL.  Diese 
organoids zeigen apoptosis in notch aktiv und radial organisierten Vesikel, Zell-
Zyklus Arrest, frühzeitige Differenzierung und Verlust der Expression von kortisch 
spezifischen Genen, wenn diese von Triple-i Methoden entwickelt worden.  Das zeigt 
eine kortisch spezifische Ätiologie, die nur in Triple-i organoids zu finden ist.  Auf 
diese Weise beschließen wir, dass die Kombination von WNT Inhibition mit dual 
SMAD Inhibition für die Standardisierung der Modellierung von der Kortikogenese 

















1.1 Early mammalian embryonic development 
Embryonic development starts with the fertilization of an oocyte by a sperm cell 
leading to the formation of a zygote. This single celled zygote now starts its journey 
from fallopian tubule to uterus, simultaneously undergoing several cell divisions to 
form the blastocyst, which gets implanted into the endometrium of uterus. The 
blastocyst consists of two distinctive cell types i) inner cell mass (ICM) which gives 
rise to the embryo and ii) an outer layer of trophoectoderm (TE) which generates 
extra embryonic tissues [1] (Figure 1). Post implantation, ICM cells differentiate into 
three germ layers known as the ectoderm, mesoderm and endoderm in a highly 
coordinated step known as gastrulation. 
 
 
Figure 1: Stages of mammalian embryogenesis from fertilization to gastrulation.  
Following fertilization, the zygote undergoes a series of cell divisions to from the blastocyst. The inner 
cell mass (ICM) of the blastocyst give rise to all three germ layers (ectoderm, mesoderm and 
endoderm). These three germ layers eventually generate different tissues of the body. Adapted from 
Neuroanatomy text book (Maria A Patestas and Leslie P. Gartner) 
 
1.2 Neurulation 
Neurulation refers to the process of formation of neural tube from the ectoderm 
subsequent to gastrulation. This process starts with thickening of the ectoderm to 
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form the neural plate, followed by bending of the neural plate to generate neural 
folds flanking the neural groove. Finally, these two neural folds fuse together leading 



















Figure 2: Steps in neurulation process  
A) Thickening of ectodermal cells to from the neural plate. B) Elevation of neural folds giving rise to 
the neural groove. C) Convergence of neural folds to form the neural tube. D) Closure and 
detachment of the neural tube from the overlying epidermis. Adapted from Gilbert 2014 
 
The early mammalian neural tube is a straight structure that eventually undergoes 
expansion leading to the formation of sac-like vesicles. The early neural tube is 
specified into three primary vesicles of the central nervous system (CNS): forebrain 
(prosencephalon), midbrain (mesencephalon) and hindbrain (rhombencephalon). 
The neural tube continues to develop and differentiate to secondary vesicles where 
the prosencephalon sub-divides into anterior telencephalon (future neocortex) and 
posterior diencephalon, which will form the thalamic and hypothalamic structures of 
the brain. The rhombencephalon also further divides into anterior metencephalon 





Figure 3: Primary and secondary brain vesicles development.  
Expansion of the neural tube results in fluid filled vesicles. A) Primary vesicle stage has three brain 
regions. B) Brain continues to develop resulting in the formation of secondary vesicles which has five 
regions. Adapted from the Anatomy and Physiology book (Open Stax resource) 
 
1.3 In vivo neural induction and patterning 
Early development of the CNS is accompanied by regional patterning of the neural 
tube along the anterior-posterior (A-P) and dorsal-ventral (D-V) axes [2, 3]. The first 
classical experiments done by Hans Spemann and Hilde Mangold in 1924 [4] 
elucidated the role of organizers in inducing neural tissue. They transplanted a tissue 
from the dorsal region (the dorsal blastopore lip consisting of the future notochord, 
mesoderm and endoderm cells) of a pigmented newt gastrula embryo into the 
ventral region (future epidermis) of a non-pigmented newt gastrula embryo, and 
found that the donor tissue induced a second nervous system in the host (Figure 4). 
This dorsal tissue that has the capacity to induce the whole nervous system is known 
as the Spemann organizer. Later studies [5-7] revealed that this organizer secreted 
bone morphogenetic protein (BMP) pathway inhibitors which induce neural tissue in 
the surrounding ectoderm. Spemann and Mangold experiments also revealed that 
early gastrula grafts gave rise to the whole nervous system while late gastrula 
organizer grafts could induce only posterior regions. This led them to postulate the 
existence of separate organizers in space and time for inducing different regions of 
the nervous system along the A-P axis [8-10]. However Pieter Nieuwkoop later 
postulated an alternate activation-transformation theory, which states the default 
acquisition (activation) of neural tissue with anterior fate (forebrain character). In the 
subsequent transformation step, this anterior neuroectoderm would gradually make 
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more posterior regions in the presence of caudal transforming factors [11-13]. 
Although growing evidence favors Nieuwkoop’s theory [3, 14], this issue still remains 
unclear. Thus, anterior fates are thought to form by default, while posterior fates are 
actively induced by caudalization factors such as FGF, WNT and retinoic acid (RA) 
signals [2, 7, 15-17]. 
 
 
Figure 4: Transplantation experiments demonstrating organizer activity of newt dorsal 
blastopore lip tissue  
Transplantation of dorsal blastopore lip tissue of pigmented newt Triturus taeniatus to non-pigmented 
newt Triturus cristatus. The transplanted donor tissue exerts an organizing activity on the surrounding 
host tissue and induces a whole new secondary axis in the host embryo. Adapted from Andoniadou, 
C.L et al - [18]. 
 
Structures similar to the Spemann organizer in xenopus are also found in other 
vertebrates such as chick (known as Henson node), zebrafish (known as embryonic 
shield) and mouse (known as node). Similar results were observed in experiments 
carried out in chick and mouse embryos, highlighting the evolutionarily conserved 
role of this organizer [19, 20]. However, in mice, the transplantation of the early 
gastrula organizer (node) could give rise to the neural axis with only posterior 
regions, lacking anterior forebrain tissue [20, 21], indicating that the mouse early 
organizer does not contain all the information for inducing an entire axis. Numerous 
studies support the idea of requiring an additional organizer like the anterior visceral 
endoderm (AVE), an extra embryonic structure for anterior neural tissue 
development [22-25]. At around mouse embryonic day E5.5, a group of cells from 
the distal region of the embryo known as the distal visceral endoderm starts 
migrating to the future anterior region of the embryo, establishing the AVE. This 
group of cells starts expressing several genes like Otx2, Lhx1, Cerebrus1, Lefty1 
and Dkk1 which are important for head/anterior forebrain formation (Figure 5) [26-
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31]. Noggin, Cerberus/Lefty and Dkk1 are inhibitors of BMP, TGF-β and WNT 
pathways, respectively, and thus help in establishing anterior neural fates. Mouse 
AVE equivalents are also found in xenopus (yolk cells), chick (hypoblast) and 
zebrafish (dorsal syncytial layer) [32-34]. However, other studies also have shown 
that anterior neural fate is not exclusively dependent on AVE, but works in synergy 
with signals from other organizers like the Spemann organizer (Node) and axial 
mesendoderm. Studies in chick embryos show that AVE/hypoblast cannot induce 
neural tissue from epiblast but can only transiently induce anterior neural markers 
such as Six3 and Otx2 [35]. This study shows that the AVE organizer is required for 
inducing a pre-neural/pre-forebrain like fate in first step, after which the anterior fate 
is established/stabilized by signals from the Node organizer. The AVE also protects 
the tissue that has acquired anterior fate from caudalizing in the second step. The 
caudal signals from the non-axial mesoderm then transform the tissue distant from 
the AVE to posterior regions in the third step. Thus, this study postulates a three-
step model of neural induction and patterning, which is a closure to Nieuwkoop’s 
model. Although it has not been clarified which of these models best represents early 
neural development, all of these studies contributed a lot in understanding early 







Figure 5: Specification of anterior to posterior brain regions in post implanted mouse embryo 
A) Formation and migration of AVE from distal to anterior site in around 5.5-6.0 dpc embryos. Around 
6.5-7.0 dpc, PS elongates and displaces ADE/AME which intermingle with the AVE. Future anterior 
and posterior forebrain is specified in the neuroectoderm tissue overlying AVE and ADE/AME 
whereas posterior brain regions are specified in neuroectoderm overlying notochord plate tissue. B) A 
host of signals conferring anterior to posterior brain regional fates. VE visceral endoderm, AVE 
anterior visceral endoderm, ADE anterior definitive endoderm, AME anterior mesendoderm, np 
notochordal plate, PS primitive streak, AF anterior forebrain primordium, PNE posterior neural 
ectoderm, PF posterior forebrain, MB midbrain, HB hindbrain, SC spinal cord, pp prechordal plate. 
Adapted from Andoniadou, C.L et al - [18]. 
 
1.4 Role of morphogens in neural induction and patterning 
1.4.1 Transforming Growth Factor-β Superfamily 
Broadly, TGF-β Superfamily signaling includes BMP and Activin/Nodal signaling 
pathways. These signaling pathways initiate with the binding of ligand to a 
heterodimeric receptor complex consisting of type I and type II receptor with a 
serine/threonine kinase domain. Following ligand binding, the type II receptor 
phosphorylates and activates the type I receptor which then phosphorylates Smad 
proteins initiating a Smad protein dependent signaling cascade. Eight Smad proteins 
operate in this signaling pathway, of which five Smad proteins (Smad1, Smad2, 
Smad3, Smad5 and Smad8) are receptor regulated Smads known as R-Smads. 
Smad2 and Smad3 are activated by Activin/Nodal signals whereas Smad1, Smad5 
and Smad8 are activated in response to BMP signals. These activated R-Smads 
now bind to a common Smad i.e., Smad4 forming RSmad/Smad4 complex, which 
then translocates to the nucleus and regulates gene expression. The other Smads 
such as Smad6 and Smad7 acts as inhibitory Smads inhibiting the signalling 
































Figure 6: TGF-β superfamily including BMP and TGF- β signaling pathways 
Binding of ligands, either BMPs or TGF-β to the respective type I and type II heterodimer receptors 
triggers the activation of Smad1/5/8 in the case of BMP signaling and Smad2/3 in the case of TGF β 
signaling. Activated R-Smads then bind to Smad 4 and translocate into the nucleus and drive the 
transcription of targeted genes. Adapted from Brzica, H et al [36]. 
 
1.4.1.1 Bone morphogenetic protein (BMP) Signaling 
Inhibition of BMP signaling is a prerequisite for the induction of neural plate from 
ectoderm. Studies identified the ability of  the Spemann organizer or the notochord in 
neuralizing the overlying ectoderm is due to the expression of BMP antagonist 
proteins like Noggin, Follistatin and Chordin, which prevent the binding of BMPs 
especially BMP-4 to its receptor, thereby inhibiting the BMP pathway [37]. Studies 
done in xenopus and zebrafish embryos treated with morpholinos against Noggin, 
Follistatin and Chordin result in loss of neural tissue [38, 39]. Mice with deficient 
BMP receptor (Bmpr1a-/-) exhibit a premature neural induction at the pre gastrula 
stage [40] and Noggin-/-Chordin-/- mutant mice fail to form proper forebrain [41]. 




1.4.1.2 Activin/Nodal TGF- β Signaling 
Although numerous studies show the importance of BMP inhibition in neural 
induction, it is not the sole player in this process. There are studies which also 
established the role of other TGF-β members like Nodal signaling in neural induction. 
Nodal signaling inhibits neural induction [42] and Nodal-/- mouse mutants show 
increased neuroectoderm specification [43]. TGF-β signaling inhibits neural induction 
as mouse ESC mutants for Cripto-/- (co-receptor for TGF- β / Nodal signaling) and 
over expression of Cerberus and lefty — inhibitors of TGF-β pathway display 
increased neural induction [28, 44, 45, 46]. Collectively, these studies reveal the 
requirement for the inhibition of TGF-β signaling in achieving neural induction. 
 
1.4.2 Fibroblast growth factor (FGF) Signaling 
Fibroblast growth factors are a family of secreted ligands that bind to their specific 
FGF receptors (FGFR1-4), following which they initiate a number of signaling 
cascades such as MAPK/ERK and PLC/Ca+2 pathways, which exhibit diverse roles 
during embryonic development. The role of FGFs in neural induction is not clear yet, 
possibly due to species-specific differences. While the default model of neural 
induction is solely dependent on inhibition of BMPs in xenopus embryos, is not 
entirely so in chick and zebrafish embryos. In chicks, epiblast cells express BMP4 
and BMP7 ligands early on and decrease their expression after specification to 
neural fates, with the concomitant expression of FGF3. Blocking FGF signaling with 
the inhibitor SU5402 results in decreased neural specification, indicating an 
important role of FGF in neural induction [47]. In zebrafish, activating FGF signaling 
indirectly inhibits BMP expression, leading to dorsalization of the embryo, whereas 
blocking FGF signaling causes increased BMP expression, resulting ultimately in 
ventralization of the embryo [48]. FGFs have also been shown to caudalize neural 
tissue in xenopus, chick and mouse embryos [49, 50]. FGF/MAPK signaling reduces 
the efficacy of BMP signaling directly through the degradation of Smad1 and 
indirectly by inducing the transcription factor ZEB2, which in turn represses the 
transcriptional activity of Smads [51, 52]. Thus, these studies support the notion that 






1.4.3 WNT Signaling 
WNT signaling is also an important pathway for neural induction as well as for the 
axis patterning process. It has roles in both cell proliferation and fate specification. 
Inhibition of WNT pathway establishes anterior fates. Studies in mice mutants of the 
WNT co-receptors Lrp5 and Lrp6 show the expansion of the anterior neuroectoderm 
[53]. Loss of the WNT inhibitor Dickkopf 1 (Dkk1) in mouse prevents the formation of 
forebrain [54]. Wnt1 is expressed in caudal midbrain-hindbrain regions, and in 
accordance, loss of Wnt1 in mouse embryos leads to defects in midbrain and 
anterior hindbrain formation [55], while Wnt8c overexpression causes the expansion 
of midbrain fates on the expanse of anterior forebrain fates [56]. In chicks, ectoderm 
explants fated to become anterior forebrain structures are transformed into posterior 
neural fates when exposed to WNT molecules [57]. A GSK3 mutant zebrafish was 
shown to exhibit increased WNT levels, resulting in the transformation of 
telencephalon and eye tissues to posterior diencephalic fates [58]. 
 
1.4.4 Retinoic acid Signaling 
RA plays an important role in posterior neural fate specification, especially in the 
formation of hindbrain and anterior spinal cord structures, by regulating the 
expression of Hox genes [59, 60, 61]. Retinol dehydrogenase, an enzyme required 
for RA synthesis, is found to be highly expressed in posterior neural regions. 
Enzymes degrading RA such as CYP26 and cytochrome P450 are also expressed 
highly in anterior neural regions and thus regulate the levels of RA along the A-P 
axis [60, 62]. In zebrafish, FGF and WNT pathways posteriorize neural ectoderm 
tissue by suppressing anterior fate specific genes independently of RA, resulting in 
induction of posterior fate specific gene expression in an RA-dependent process 
[60]. RA is also important for dorso-ventral (D-V) patterning, where RA along with 
BMP antagonist Follistatin are expressed in response to SHH in the regulation of 
ventral patterning. 
 
1.4.5 Sonic Hedge Hog Signaling 
SHH plays a key role in assigning the dorso-ventral axis of the neural tube. In the 
anterior neuraxis, structures such as the pallium (cerebral cortex) and subpallium 
(basal ganglia) are present on the dorsal and ventral regions, respectively. In the 
posterior neuraxis, such as the spinal cord, motor neurons reside ventrally and 
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sensory neurons dorsally. Broadly, the D-V axis identity is determined ventrally by 
activation of Nodal and SHH and dorsally by BMP/Wnt [63]. SHH is secreted from 
the notochord and induces the ventral structures along the neural tube as well as the 
floor plate [64]. Mice Shh null mutants show an absence of ventral structures, small 
diencephalon and midbrain structures [65] and miss the ventral half of the spinal 
cord, while retaining the dorsal half [66]. Ectopic Shh expression in mouse dorsal 
neural tube and Patched1 (SHH receptor) mutant mice show hyper proliferative 
phenotypes [67, 68], indicating the role of SHH in cell proliferation. 
 
1.5 Pluripotent stem cells – A powerful platform to study embryogenesis 
Embryonic development starts with the formation of an unspecialized zygote, which 
eventually gives rise to an embryo consisting of hundreds of specialized cell types. 
As development proceeds, cells undergo restriction in their developmental potential. 
Embryonic stem cells are pluripotent cells derived from the inner cell mass of the 
blastocyst, which are able to self-renew and differentiate into the three germ layer 
cells – ectoderm, endoderm and mesoderm. A mouse ESC was first generated in 
1981 by isolating the ICM from the blastocyst [69, 70], and later in 1998, a human 
ESC line was established [69, 70] and later in 1998 human ESC line was established 
[194]. The enormous capacity of ESCs to maintain differentiation potential towards 
distinct cell types makes them an indispensable tool for developmental studies, 
disease modeling and regenerative medicine applications [71, 72, 73]. It should be 
noted that the use of hESCs is limited due to ethical, technological and tissue 
availability reasons. Also, issues related to immune rejections following cell 
replacement therapies further complicate the use of ESCs in stem cell therapy. 
 
Earlier studies demonstrated the ability of somatic cells to regain the pluripotency 
state using somatic cell nuclear transfer [74, 75] and fusion with ESCs [76, 77], 
indicating the presence of factors in oocytes and ESCs that can reprogram somatic 
cell to a pluripotent cell state. In 2006, ground-breaking work done by Takahashi and 
Yamanaka resulted in successful reprogramming of mouse fibroblasts to embryonic 
stem-like cells known as induced pluripotent stem cells using four transcription 
factors Oct3/4, Sox2, c-Myc and Klf4 [78]. IPSC technology holds great promise due 
to its ability to generate patient-specific PSCs that are highly useful for potential cell 
replacement based therapies, disease modeling and drug development and 
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tolerability tests [79, 80]. IPSCs also have the advantage of circumventing the major 
ethical issues concerning the use of ESCs. Although they behave similarly to ESCs 
to a large extent, iPSC lines still require a rigorous characterization as their complete 
epigenetic reprogramming is still in question [81, 82]. However, the full harnessing of 
ESCs or iPSCs for regenerative medicine applications depends mainly on the 
availability of efficient differentiation protocols to generate cells of interest at high 
purity. The main challenge of any differentiation scheme is to obtain an enriched 
target cell population. This depends on many factors such as cell density, type of 
differentiation platform: monolayer, EBs or 3D organoids; how well defined the types 
or batches of knock-out serums used are, the degree and extent of use of 
morphogens or small molecule inhibitors, which contribute as well to high variability 
in terms of cell types generated. Nonetheless, PSCs provide a powerful and 
unlimited source to generate and study different cell types such as neural lineage 
stem cells, which our lab is mainly interested in, thus enabling the experimental 
study of otherwise inaccessible cell types. 
 
1.6 Neural stem cells 
NSCs are multipotent cells that can self-renew and differentiate into neurons, 
astrocytes and oligodendrocytes [83, 84]. The neural tube consists of a one cell thick 
layer of early NSCs known as neuroepithelial cells (NE) whose nuclei are arranged 
at different height’s ranging from the inner luminal site to the outer surface leading to 
a pseudostratified epithelial arrangement [85]. NSCs emerge during the development 
of the nervous system and continue to exist in adults [83, 84]. Heterochronic 
transplantation studies have revealed the loss in stem cell potency as development 
proceeds, i.e., early NSCs have the broad potency to give rise to all neural cell types 
whereas later derived NSCs have restricted potency and are incapable to give rise to 
early cell types [86, 87, 88]. Embryological transplantation studies in xenopus, chick 
and mice elucidated the role of morphogens (discussed above in detail) in the 
patterning of NSCs across the A-P and D-V axes during the nervous system 
development. Together, these findings suggest that the potential of NSCs is 
restricted both spatially and temporally and this dynamic changing nature of NSCs 
during developmental progression plays a key role in producing the enormous neural 
cell type heterogeneity in the central nervous system [88]. Therefore, more work 
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needs to be accomplished for further dissecting heterogeneity in vivo and in vitro 
based on novel distinct markers. 
 
1.7 NSCs in cerebral cortex development 
The cerebral cortex or neocortex is the largest and most complex structure of the 
mammalian brain and is involved in higher order brain functions such as perception, 
cognitive abilities, language, memory and consciousness. The neocortex is specified 
in the most anterior and dorsal region of the early embryonic neural tube, whose 
development starts with the generation of a single layer of epithelial cells from the 
ectoderm known as neuroepithelial cells arranged in a pseudo-stratified manner. NE 
cells are early NSCs that are highly polarized in nature showing apico-basal polarity, 
with their apical sites facing the lumen of the neural tube forming ventricular zone 
(VZ) and basal site towards the basal lamina. The nuclei of NE cells undergo a 
unique migration process along the apico-basal sites during the cell cycle known as 
Interkinetic nuclear migration (INM) (Figure 7) [89, 90]. In this process, during G1-S 
phase of cell cycle, nuclei migrate from apical to basal site and undergo ‘S phase-
DNA replication’ at the basal site. Then the nuclei migrate back to the apical site 




















Figure 7: Interkinetic nuclear migration of neural stem cells 
Nuclei of neuroepithelial (A) and radial glial cells (B) exhibiting migration from apical to basal site 
depending on the phase of their cell cycle. During G1 phase nuclei migrate from the apical-basal site 
with DNA replication (S-phase) occurring at the basal site. In contrast nuclei returns to the apical site 
during G2 phase with cell division (mitosis) taking place at the apical site. VZ ventricular zone, SVZ 
sub-ventricular zone and CP cortical plate. Adapted from Taverna, E et al [89].  
 
During cortical development, NE cells first divide symmetrically giving rise to two 
identical daughter stem cells resulting in expansion of the NSC pool. This phase is 
then followed by asymmetric cell divisions that generate one stem cell and an 
intermediate progenitor (IP) or a neuron, resulting in decreased NSC ratios [91]. 
During this phase, NE cells transform into a distinct fate restricted NSC type with 
astro-glial characteristics known as radial glial (RG) cells [92, 93]. RG cells still 
maintain polarity, perform INM and undergo cell division in the VZ, although they 
already start to express astroglial markers [91, 92]. On the other hand, the generated 
IP daughter cells detach and migrate basally, forming the sub-ventricular zone (SVZ) 
through consecutive cell divisions. IP cells lack apico-basal polarity and undergo few 
rounds of proliferative divisions yielding more IPs, and finally produce neurons. 
Another class of RG cells known as basal radial glial (bRG) cells were found in the 
outer SVZ (oSVZ), which lacks apical attachment with the VZ but still maintains the 
basal process and is thought to contribute to expansion and gyrification of the cortex 
in large-brain primates [94-96]. Neurons generated either from NE, RG or IP cells 
migrate basally to the SVZ and accumulate in a timely manner, forming the cortical 
plate (CP) in a process known as cortical lamination. The neocortex is a highly 
complex structure with hundreds of neuronal cell types distributed across six layers 
(Layer I - Layer VI), formed in an inside-out fashion, where the oldest neurons (Layer 
VI) accumulate in the deep layers and the youngest neurons (Layer II) migrate past 


















Figure 8: Cortical lamination in mouse neocortex 
NE cells residing in the VZ initially undergo symmetrical cell division to expand its pool and then attain 
radial glial morphology. RGC divides asymmetrically to generate either IPC which occupies SVZ or 
neurons reaching CP in a time dependent manner. Subplate neurons are generated first, followed by 
DL neurons destined to L6/L5 and finally UL neurons destined to L2/3/4. Once neurogenesis is 
completed RGC then becomes gliogenic and give rise to astrocytes and oligodendrocytes and then 
transforms into adult neural stem cells known as ependymal cells occupying SEZ. NE neuroepithelial 
cells, RGC radial glial cells, VZ ventricular zone, SVZ sub-ventricular zone, IPC intermediate 
progenitor cells, MZ marginal zone, SP subplate, CP cortical plate, CZ Cazal Retzius cells, BV, blood 
vessel; CR, Cajal-Retzius neuron; DL Pyr, deep-layer pyramidal neuron; IZ, intermediate zone; UL 
Pyr, upper-layer pyramidal neuron, WM, white matter, EL ependymal cells, SEZ subependymal zone, 
Ast astrocytes. Adapted from Kwan, K.Y et al [98] 
  
The neurons generated earliest during cortical neurogenesis are Cajal-Retzius and 
subplate neurons. Cajal-Retzius neurons are the main source of reelin, a secreted 
protein important for normal cortical lamination [99]. The deep cortical layers (layer 
V-VI) consist of corticofugal projection neurons, of which Layer VI neurons project 
their axons to the thalamus (corticothalamic neurons) and Layer V neurons interact 
with the midbrain tectum (corticotectal neurons), brainstem or pons (corticopontine 
neurons) and spinal cord (corticospinal motor neurons). Studies in mice revealed 
that these deep layer cortical neurons are characterized by marker transcription 
factors such as Tbr1, Ctip2 and Fezf2, by showing that their absence leads to 
improper cortical lamination process [100, 101, 102]. Upper layer neurons (Layer 
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II/III, IV) consist of callosal projection neurons, which project axons within the cortex 
(intracortical)-connecting both cerebral hemispheres via the corpus collasum and 
expressing transcription factors such as Cux1 and Cux2, Brn1 and Brn2, and Satb2 
(Figure 9) [103 -109]. Once the upper layer neurons are generated, radial glia stem 
cells now switch their neurogenic fate to gliogeneic fate, thereby giving rise to glial 
cells such as astrocytes and oligodendrocytes. Astrocytes nourish the neurons by 
supplying nutrients and oxygen, maintaining CNS homeostasis, whereas 
oligodendrocytes coat the axons of neurons with a lipid rich myelin sheath providing 
insulation and thereby enhancing transduction of nerve electric impulses. Altogether, 
these mechanisms are fundamental for the generation of distinct types of NSCs and 
their progeny that account for the enormous cellular diversity of the cortex. 
 
 
Figure 9: Schematic representation of cortical projection neurons connections 
Deep layer cortical neurons (Layer V/VI) project their axons into the thalamus, midbrain tectum, 
brainstem (pons) and spinal cord. Upper layer neurons (Layer II/III/IV) connect both cerebral 
hemispheres via the corpus collasum. Adapted from Molyneaux, B.J et al [110]. 
 
1.8 Recapitulating in vivo neural induction and patterning in vitro using PSCs 
The advent of PSC biology has led us to utilize these cells and generate in vitro 
models for early development, poorly understood diseases and target cell 
populations for regenerative cell therapies. In vitro neural induction experiments are 
dated back to the early 1990s, where the xenopus animal cap (future ectoderm) 
explants cultured in simple pond saline water produced epidermal fates. However 
when these explants were dissociated and plated as single cells, they gave rise to 
neural fates [111], although they did restore epidermal fate when exposed to BMP-4 
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ligand [112], indicating that the loss of cell-cell contact diluted BMP/TGF-β signaling 
that in turn specified them to neural fates. Thereafter, studies showing the necessity 
of the inhibition of BMP/TGF-β signaling in mammalian PSCs to achieve neural 
induction are continuously emerging, showing the evolutionarily conserved 
mechanism. 
 
Neural induction methods using both mouse PSCs (mPSCs) and human PSCs 
(hPSCs) have undergone many modifications to date, starting from culturing PSCs 
as embryoid bodies (EBs) in serum, through culture on a feeder layer, then in a 
chemically defined medium with small molecule inhibitors, to the recently developed 
organoid technology (Figure 10) [113]. Early studies that involved screening of 
feeder layers revealed that bone-marrow derived stromal cells could promote strong 
neural induction in mPSCs, although the exact role of stromal cells remains unclear 
[114]. Mouse PSCs cultured under low density-mimicking xenopus experiments-
generated neural progenitors albeit with less efficiency (0.2%), but in the presence of 
Noggin and Cerebrus (mCer1) and with Smad4-/- null mESCs (resistant to 
BMP/TGF-β signaling) showed an increased neural progenitor derivation [115]. 




Figure 9: Timeline of in vitro neural induction protocols from human or mouse PSCs 
Schematic showing different neural induction protocols for the generation of neural/cortical tissue. 
Adapted from Kelava, I et al [113]. 
 
Zhang and colleagues first reported the generation of neural tube like structures 
known as neural rosettes by culturing hPSCs as EBs in the presence of FGF2 [116]. 
These neural rosette precursors generated neurons, astrocytes and 
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oligodendrocytes upon mitogen removal. Another study from Ying et al. reported the 
neural induction by plating mPSCs as adherent monolayer culture instead of EBs, in 
the absence of serum and other neural inductive signals [117]. The method launched 
by the Sasai group utilized Nodal and WNT pathway antagonists for derivation of 
general telencephalic fates from mouse PSCs [118]. We later recapitulated this 
default neural induction mechanism in human PSCs and isolated neural rosette-
forming NSCs corresponding to early radial glial like NSCs with anterior/cortical 
character using the BMP antagonist Noggin [119, 120]. This method was significantly 
improved by the same group by adding TGF beta inhibition – becoming the widely 
accepted dual SMAD inhibition protocol in human PSCs [121]. Parallel studies 
showed a time-dependent sequential production of cortical neurons by diverse 
methods using SHH antagonist and relying on intrinsic signals [122], to using 
different combinations of TGF, BMP and WNT signaling inhibition with or without 
FGF signaling modulation [123-125]. WNT and dual SMAD inhibition were also used 
in combination with SHH activation to accelerate specification of cortical interneurons 
[126]. We recently used dual SMAD inhibition to recapitulate the generation of the 
building blocks of corticogenesis from human PSCs based on their Notch activation 
state using a Notch activation reporter as readout [127]. We showed that the timed 
and ordered production of deep followed by superficial layer neurons and then glia 
could be remarkably recapitulated by consecutively isolated Notch active 
progenitors. While this latter paradigm yielded cells that were enriched but not 
restricted to cortical fates, these building blocks of corticogenesis were very well 
reiterated in vitro due to high stem cell state present in each of the isolated 
progenitor populations due to Notch activation enrichment. However, the use of 
many successful yet distinct approaches over the years reflected inconsistency in 
recapping cortical differentiation principles in vitro. We reasoned that this diversity 
mirrors a general lack in robust and direct readout to assess efficiency of 
differentiation already at early phases of differentiation, rather than assessing fate 
potential throughout hundred days and more in culture, urging for a more 
standardized method for efficient derivation of specified dorsal telencephalic 
(neocortical) neuroepithelial cells and their progeny. 
 
Parallel to 2D differentiation systems, in recent years there has been an astounding 
increase in the use of brain organoid models, enabling an in vivo-like view of 
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fundamental neurodevelopmental features and processes. This in turn evoked, 
again, an explosion of methods to derive these 3D structures for modeling 
development and disease, with protocols ranging from inhibitor-free conditions [128, 
129, 130] to dual SMAD inhibition [131, 132] or TGF/WNT inhibition [133-136]. 
Nonetheless, organoids are complex structures and are inherently heterogeneous. 
Heterogeneity is postulated to be reflected in both the robustness of neural induction 
as well as the bias in regional identity, possibly due to the fact that organoids can 
well form in the absence of defined extrinsic cues, allowing inherent differences in 
local inductive signals within individual organoids. Nevertheless, a major hindrance 
for regenerative medicine is still the poor ability of such protocols to generate 
homogenous cortical neural stem cells and their progeny, an essential component 
for future cell replacement based therapies, as well as for gaining a better 
understanding of disease etiology and progression. As the biology of cerebral 
organoids is only beginning to unravel, these observations together urge for both 
further improving strategies for developing more defined 3D organoid systems 
alongside with continuous efforts to enhance the homogeneity of the more simplified 
2D cultures that yield cells in a more single cell or clonal level.  
 
Collectively, this continuously evolving diversity in differentiation paradigms also 
causes inconsistencies in the way cortical differentiation principles and disease 
modeling phenotypes are interpreted and conceived by the community. We 
reasoned that this diversity mirrors a general lack in robust and direct readout to 
measure specification efficiency during early phases of differentiation, namely 
accurately capturing the purity of the starting population. Second is the scarcity of 
specific genes that unequivocally mark cortical cell populations. Furthermore, 
assuming expression of very late markers appearing after more than a hundred days 
in culture as gold-standard probes to assess differentiation adds controversy on how 
results with such markers should be interpreted. Finally, different methods are not 
run in parallel in the same study, questioning the validity of disease phenotypes. 
These concerns urge for more standardized methods for efficiently assessing 






1.9 Notch signaling and Rosette formation - a tool for measuring efficiency of 
cortical specification 
The Notch signaling pathway plays a major role in nervous system development by 
regulating cell fate decisions. The Notch gene encodes receptor transmembrane 
proteins (Notch1-4) consisting of an extra cellular domain (NECD), transmembrane 
domain (TM) and intra cellular domain (NICD). Signal conveying cells express 
ligands such as Delta-like (Dll1, Dll3 and Dll4), Jagged (Jag1 and Jag2), and bind to 
the Notch receptors on signal receiving cells. Ligand binding results in two proteolytic 
events. First NECD is cleaved from TM-NICD, mediated by TACE (TNF-α ADAM 
metalloprotease converting enzyme). Second NICD is cleaved from TM, mediated by 
γ-secretase. Ligand bound to NECD is then endocytosed and recycled in signal 
sending cells. In signal receiving cells, the cleaved NICD then translocates to the 
nucleus and binds with transcription factor complex CSL (CBF1/Su(H)/Lag-1) in 
drosophila / RBP-Jk in mammals resulting in the activation of Notch target genes like 
Hes family genes, MYC, p21 etc.,  
 
The basic helix-loop-helix (bHLH) genes Hes1 and Hes5 are important notch 
effectors that are crucial for the maintenance of neural progenitors in the mammalian 
neural tube. In mice deficient of Hes1 [137-138] and Hes5 [141] premature neural 
differentiation was observed along with severe abnormalities in neural tube 
formation, anencephaly and eye formation. Similar precocious neural differentiation 
phenotype at the expense of progenitor maintenance was observed in Notch1 and 
RBP-Jk deficient mice [139]. Conversely, activation of Notch signaling by over 
expression of NICD or Hes genes (Hes1 and Hes5) overexpression in neural 
progenitors resulted in the inhibition of neural differentiation and promoted radial glia 
identity [140, 141]. The expression of Hes5 correlates with the expression of Notch1 
in the nervous system [142] and also shows better correlation with neural stem cell 
potential compared to Hes1 [143]. Thus, Notch activation, in turn the expression of 
downstream targets like Hes1 and Hes5 are important for neural stem/progenitor cell 
maintenance during nervous system development. 
 
Formation of neural rosettes is a critical morphogenetic event occurring during 
nervous system development. Differentiation of PSCs into cortical lineages is 
reflected by the formation of neural rosette structures comprising of NSCs that are 
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radially organized, thus creating a lumen resembling the VZ of a developing cortex. 
Moreover, rosettes NSCs undergo cell division at the rosette apical sites resembling 
in vivo apical mitosis in the VZ [144, 145]. Our earlier studies identified a novel type 
of NSCs from PSC termed as rosette neural stem cells (R-NSCs) with 
anterior/cortical character. These R-NSCs have considerable self-renewing abilities 
and broad potency towards CNS fates [119]. We showed that Notch activation is 
essential for radial organization (rosette formation) which in turn is abrogated in the 
presence of Notch signaling inhibitors [119]. We further coupled Notch activation and 
radial organization to cortical neurogenesis by showing that only cells obtained from 
mechanically isolated Notch active radially organized structures (i.e. rosettes) could 
give rise to cortical neurons in a time and cortical layer dependent manner [127]. We 
also validated this correlation at the molecular level by revealing transcriptional and 
epigenetic factors associated with corticogenesis that drive Notch activation at the 
rosette stage [146]. Finally, we also demonstrated that Notch active cells within 
rosettes performed interkinetic nuclear migration – the hallmark phenomenon of 
cortical differentiation and then used this feature as a cytoarchitectural quantitative 
readout for cortical differentiation at the rosette stage [147]. This quantitative readout 
has the potential to serve for functional molecular studies, drug screening, and may 
be implicated to gain novel insights into biology of NSCs in health and disease. 
Taken together, our recent data propose that radial organization and Notch 
activation are linked hallmarks of the transition of PSCs into anterior/ cortical fates – 
and hence could be used as readouts for improving methods for streamlining cortical 
fates and also help better understanding of cortical disorders involving defects in 
NSC proliferation and differentiation such as microcephaly. 
 
1.10 Modeling cortical neurodevelopmental disorders 
Autosomal recessive primary microcephaly (MCPH) is a neuro developmental 
disorder in which patients are born with reduced brain size and show mild to severe 
mental retardation. Clinically, microcephaly is defined as having a head 
circumference more than two standard deviations (>-2 std.dev) below the mean for a 
patient’s given age and sex. Microcephaly is a genetically heterogeneous disease 
and there are at least 10 loci in proteins such as Microcephalin, ASPM, CDK5RAP2, 
CENPJ and STIL which are associated with microcephaly [148-152]. Most of these 
proteins have functions related to centrosome, mitotic spindle, DNA repair etc, 
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linking the disease due to a disruption in cell cycle and cell division activities. It is 
predicted that these microcephaly mutations cause disturbances in NSC 
proliferation, differentiation and cell death kinetics that would impair stem cell pool, 
thereby leading to the generation of a lesser number of neurons and thus to a small 
brain phenotype. The recent outbreak of Zika virus (ZIKV) in South America with its 
suspected link to causing microcephaly in new-borns has put stem cells at the 
forefront of neuro developmental disorder research. ZIKV transmits from infected 
mother to foetus causing congenital defects like microcephaly to infected new-born 
babies [153]. Recent studies show that ZIKV readily infects cortical neural stem cells 
and affects their cell cycle progression, causing death of both cortical stem cells and 
neuronal cell types [132, 154-156]. 
 
In this thesis, we have worked on a microcephaly disease model caused due to 
mutations in STIL gene. The STIL gene (or SIL; SCL/TAL1 interrupting locus) was 
initially found to be associated with the chromosome rearrangement site causing T-
cell acute lymphoblastic leukaemia [157] and later studies found that it is involved in 
centriole duplication. Indeed, STIL depletion blocks centriole duplication whereas its 
overexpression leads to centrosome amplification [158-160]. Stil-/- knock out mice 
display numerous abnormalities such as neural tube defects, loss of left-right axis 
symmetry and die after E10.5 [161]. STIL mutations linked with primary microcephaly 
are predicted to generate truncated proteins (p.Val1218X and p.Gln1239X) causing 
loss of 49 and 69 amino acids from the C-terminus. The STIL protein has several 
conserved domains like proline rich CR2 domain that interacts with other 
centrosomal proteins such as CPAP/CENPJ, the coiled-coil (CC) domain, which 
interacts with PLK4 and CDK1 proteins [162, 163], and is important for STIL 
oligomerization [164], the STAN domain interacting with SAS-6 protein and important 
for centriole duplication [163], and the KEN domain at the C-terminus, which is 
important for its degradation mediated by anaphase promoting complex/cyclosome 
(APC/C). Arquint and Nigg found that STIL microcephaly mutations generate 
truncated proteins with the loss of the KEN domain making them resistant to APC/C 
mediated degradation. Thus, the protein stabilizes and represents a gain of function 
phenotype [165]. However, it is not clear how the mutation in a centrosomal protein 




Although conventional animal models like rodents have been a source for 
understanding many human disease etiologies, modeling neuro developmental and 
psychiatric disorders like microcephaly, autism and schizophrenia in animals is 
difficult, due to the inherent species-specific differences in size, architecture, cell 
types and functions of brain. The recent emergence of PSC derived human brain 3D 
organoid technology which mimics in vivo brain development and architecture 
provides a good platform to investigate the etiology of these neuro developmental 
disorders. However the diversity in the 3D organoid derivation methods ranging from 
using inhibitor free methods to different combinations of pathway inhibitors (as 
described above) mirrors the lack of a unified or gold standard method to derive 
homogeneous cortical organoids that can best be used to interpret the cortical 


























2. MATERIALS AND METHODS 
 
2.1 Cell lines 
• HES5::eGFP H9 human Embryonic stem cells (hESCs), Wicell Research 
Institute (WA-09, XX) 
• Microcephaly STIL mutant HES5::eGFP H9 human Embryonic stem cells 
(hESCs), Wicell Research Institute (WA-09, XX) 
• ZIP8K8 induced pluripotent stem cells 
• Mitotic-arrested mouse embryonic fibroblasts (MEFs), Globalstem 
 
2.2 Reagents 
• DMEM/F12 (Gibco) 
• Knock-out DMEM (Invitrogen) 
• Neurobasal medium (Gibco) 
• mTeSR1 medium (Stem Cell Technologies) 
• Knockout serum (KSR, Gibco) 
• 1mM Glutamine(Gibco) 
• GlutaMAX (Invitrogen) 
• Penicillin-streptomycin (Gibco) 
• MEM non-essential amino acids (MEM-NEAA, Gibco) 
• Beta-Mercaptoethanol (Invitrogen) 
• Fetal bovine serum heat inactivated (FBS, Gibco) 
• Di methyl sulphoxide (DMSO, Sigma) 
• Insulin (Sigma) 
• Apotransferin (Sigma) 




• Sodium bicarbonate(Sigma) 
• Gelatin powder (Sigma) 
• Matrigel (BD Biosciences) 
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• Polyornithine (Sigma) 
• Fibronectin (BD Biosciences) 
• Laminin (BD Biosciences) 
• Paraformaldehyde (PFA; Sigma-Aldrich) 
• Picric acid 
• Sucrose (Sigma-Aldrich) 
• Optimal cutting temperature compound (OCT, Tissue-Tek) 
• Bovine serum albumin (BSA, Sigma) 
• Triton-X100 (Sigma) 
• Trypan blue (Gibco) 
• D-PBS without calcium and magnesium (Gibco) 
• Growth factors and small molecule inhibitors 
• Basic fibroblast growth factor 2 (bFGF2, R&D) 
• Transforming growth factor-β1 (TGF-β1,Peprotech) 
• Noggin (R&D) 
• SB-431542 (Tocris) 
• XAV (Tocris) 
• Fibroblast growth factor 8 (FGF8, R&D) 
• Brain derived growth factor (BDNF, R&D) 
• Epithelial growth factor (EGF, R&D) 
• L-Ascorbic acid (Sigma) 
• B27 – vitamin A supplement (Gibco) 
• B27 + vitamin A supplement (Gibco) 
• ROCK inhibitor (Y27632, Tocris) 
• Neutral protease (Dispase, Worthington) 
• Accutase (Sigma-Aldrich) 
• Deoxy ribonuclease (DNase I, Worthington) 
• Papain dissociation system (Worthington) 
• trypLE (Gibco) 
• 0.5M EDTA (Invitrogen) 




2.3 Molecular biology application kits  
• DNeasy Blood & Tissue Kit (Qiagen) 
• Plasmid Plus Midi Kit (Qiagen) 
• miRNeasy Mini Kit (Qiagen) 
• RNase Free DNase Set (Qiagen) 
• High Capacity cDNA Reverse transcription Kit (Applied Biosystems) 
• FastStart Universal SYBR Green Master (ROX, Roche) 
• Phusion High-Fidelity PCR Kit (New England Biolabs) 
 
2.4 Reagents preparation 
hESC medium (500 ml) 
To 386.5 ml of DMEM/F12, add 100 ml of KSR, 2.5 ml of GlutaMAX, 5 ml of MEM-
NEAA, 5 ml of Penicillin-Streptomycin and 0.5 ml of beta-mercaptoethanol. Filter it 
using a vacuum-driven 0.2-μm filter unit, store at 4°C and use at room temperature 
(RT).  
 
mTESR1 medium (500 ml) 
To 400 ml of mTESR1 basal medium, add 100 ml of mTESR1 5X supplement and 5 
ml of Penicillin-Streptomycin. Filter it using a vacuum-driven 0.2-μm filter unit, store 
at 4°C and use at room temperature (RT). 
 
KSR medium (500 ml) 
To 409.5 ml of Knockout DMEM, add 75 ml of KSR, 5 ml of GlutaMAX, 5 ml of MEM-
NEAA, 5 ml of Penicillin-Streptomycin and 0.5 ml of beta-mercaptoethanol. Filter it 
using a vacuum-driven 0.2-μm filter unit, store at 4°C and use at room temperature 
(RT). 
 
Neurobasal medium (500 ml) 
To 484.5 ml of Neurobasal medium, 5 ml of GlutaMAX, 5 ml of MEM-NEAA, 5 ml of 
Penicillin-Streptomycin and 0.5 ml of beta-mercaptoethanol. Filter it using a vacuum-





N2 medium (500 ml) 
To 490 ml of DDW, add 6.5 g of DMEM/F-12 powder, 0.775 g of D-Glucose, 1 g of 
Sodium bicarbonate, 5 mg of Apo-transferrin, 12.5 mg of insulin, 30 µl of 500µM 
Sodium selenite, 100 µl of 830nM Putrescine, 100 µl of 100µM Progesterone and 5 
ml of Penicillin-Streptomycin. Filter it using a vacuum-driven 0.2-μm filter unit, store 
at 4°C and use at room temperature (RT). 
 
Dispase solution 
Reconstitute 50 mg of dispase powder with indicated activity of C units/mg dry 
weight (=50C units) in a desired volume (=50C/4) of hESC medium to get a working 
activity of 4 units/ml. Filter the solution using a vacuum-driven 0.2-μm filter unit, store 
at -20°C and use at RT. 
 
EDTA solution 
Add 200 µl of 0.5M EDTA to 200 ml of DPBS and filter it using a vacuum-driven 0.2-
μm filter unit, store and use at RT 
 
Fixing and staining solutions 
4% PFA and 0.15% Picric acid solutions (250 ml) 
Heat 200 ml of PBS to 58-60°C in a beaker on a magnetic heating plate and add 10g 
of PFA with continuous stirring with magnetic stirrer and add few drops of 1N NaOH 
for complete dissolving of PFA. Once the PFA is dissolved and the solution is clear, 
make up the rest of the volume to 221 ml with PBS and let it stand to come to room 
temperature. Add 28.8 ml of 1.3% Picric acid and adjust the pH to 7.4 by using 10N 
NaOH. Store it at -20°C and use at RT. 
 
PB (PBS/BSA, 500 ml) and PBT (PBS/BSA/Triton X100, 200 ml) solutions 
To 539 ml of DDW, add 7 g of BSA, 70 ml of 10X PBS and 70 ml of FBS and stir 
continuously on a magnetic plate with a magnetic stirrer inside until the solution is 
completely dissolved and appear clear. Take 485 ml of PB solution, add 15 ml of 
PBS and filter it using a vacuum-driven 0.2-μm filter unit. Store at 4 oC and use at 
RT. To the remaining 194 ml of PB solution, add 6 ml of 10% Triton X100 and mix 
well. Filter it in to a separate 200 ml bottle using a vacuum-driven 0.2-μm filter unit. 




2.5 Generation and culture of hESCs line 
The BAC transgenic HES5::eGFP Notch activation human ES cell reporter line has 
been derived from the H9 (WA-09, XX) human ES cell line (Wicell) and described 
previously [166]. Undifferentiated HES5::eGFP hES cell lines were cultured on 
mitotically inactivated mouse embryonic fibroblasts (Globalstem) and maintained in 
medium containing DMEM/F12, 20% KSR, 1mM Glutamine, 1% 
Penicillin/Streptomycin, non-essential amino acids, beta-mercaptoethanol and 
supplemented daily with 10 ng/ml FGF2 (R&D), and passaged weekly using Dispase 
(Worthington) to maintain their undifferentiated state. 
 
The microcephaly STIL HES5::eGFP Notch activation reporter line was generated 
using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 
genome editing system to introduce a nonsense mutation at the STIL locus in the H9 
(WA09)-derived HES5::eGFP hESC reporter line. This nonsense mutation mimics 
the microcephaly STIL1218 (designated in this study as MC) mutation in which 
deletion of the nucleotide (nt) G (at 3655 nucleotide position) leads to a premature 
stop codon (Val1219X). A 21-nt guide RNA (gRNA) sequence and a 150-nt ssDNA 
oligo (IDT, PAGE purified) were designed to target and generate double-strand 
breaks within the STIL ultimate exon (exon no.17) upstream to the KEN domain and 
result in the generation of a truncation mutation via non-homologous end-joining 
(NHEJ) and homology-directed repair (HDR). This gRNA was cloned into pSpCas9 
(BB)-2A-GFP (PX458, Addgene) plasmid downstream of U6 promoter using the 
Gibson assembly cloning method. hESCs (400,000 cells) were nucleofected 
(Amaxa) with 1.5 μg of SpCas9 plasmid cloned with gRNA and 1 μg of the ssDNA. 
Ninety-six hours after nucleofection, cells were sorted for GFP signal by FACS. 
Sorted cells were replated at clonal density (5K) on MEFs supplemented with MEF-
conditioned media and 10 μM ROCK inhibitor with daily fresh 10 ng/ mlFGF2. 
Individual colonies were manually picked and cultured in 24 well plates for a week 
and later expanded in 6 well plates as individual clones. Genomic DNA was 
extracted from each clone and targeted genomic region was sequenced. The 
microcephaly STIL mutant human ES cell reporter line were cultured on mitotically 
inactivated mouse embryonic fibroblasts (Globalstem) and maintained in medium 
containing DMEM/F12, 20% KSR, 1mM Glutamine, 1% Penicillin/Streptomycin, non-
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essential amino acids, beta-mercaptoethanol and supplemented daily with 
10 ng ml−1FGF2 (R&D), and passaged weekly using Dispase (Worthington) to 
maintain their undifferentiated state. 
 
2.6 Generation and culture of iPSC line 
The ZIP8K8 iPSC line was derived from Human dermal fibroblast (HDF) cells were 
obtained from a 40 year old Caucasian male with no history of genetically inherited, 
neurological or metabolic disorders using a 3 mm punch biopsy. Briefly, biopsy 
material was segmented into smaller fragments, plated onto tissue culture-treated 
plastic dishes and maintained in HDF medium containing DMEM Glutamax, 1% 
Penicillin/Streptomycin and 20% fetal calf serum at 37°C and 5% CO2. HDF medium 
was changed every other day to obtain a 90% confluent monolayer until the cells 
were passaged at a 1:3 ratio using trypsin. Pluripotent stem cell lines were induced 
using episomal plasmids following a published protocol with minor modification  
[167]. All plasmids were a gift by Shinya Yamanaka and obtained via Addgen 
(http://www.addgene.org). Briefly, 2 µg of pCXLE-hSK (#27080), pCXLE-hUL 
(#27078) and pCXLE-hOCT3/4-shp53F (#27077) were transfected into 106 HDFs 
using the Neon microporator device with 100 µl electroporation tips (Settings: 1.650 
V, 10ms, 3 timed pulses; Thermo Fisher Scientific) according to the manufacturer's 
protocol. Transfected cells were resuspended in 10 ml fibroblast medium containing 
90% 1x MEM (Thermo Fisher Scientific) supplemented with 10% FCS, and 2.5x104 
HDF/cm2 were reseeded onto Matrigel coated (0.5 mg/ml) six-well plates. Two days 
post transfection, fibroblast medium was replaced with TeSR-E7 (Stemcell 
Technologies) and cells were fed every other day with 2 ml TeSR-E7/well. On day 
26-30, post transfection emerging hiPSC colonies were picked and transferred onto 
Matrigel-coated plastic dishes (Corning; 0.5 mg/ml) in TeSR-E8 medium (Stemcell 
Technologies) for further expansion. Enzyme-free colony expansion using EDTA 
was performed every 3-4 days at a 1:6 ratio based on a protocol previously 
described [168]. Expression of pluripotency markers as well as tri-lineage 
differentiation markers for this iPSC line was confirmed by qPCR, immunostaining 
and FACS sorting assays. 
 
The Fragile X FX1 iPSC line was derived by infection and STEMCCA-OKSM 
lentivirus Dox induction of Fragile X patient (male) obtained fibroblasts (Cat. 
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#GM05131, Coriell Inst.), generated by the Hanna Lab and described previously 
[169]. FX1 iPSCs were cultured on feeder-free matrigel coated plates (1:100) and 
grown in mTeSR™1 medium (Stemcell Technologies), supplemented with 1% 
Penicillin/Streptomycin and daily complemented with 8 ng/ ml FGF2 (R&D) and 2 
ng/ml TGF-β1 (Peprotech), and passaged every 4-5 days using trypLE (Gibco) to 
maintain their undifferentiated state, as described previously [169]. 
 
2.7 Neural induction and rosette formation from pluripotent stem cells using 
the small EBs protocol 
 
Day 0 
For Feeder dependent pluripotent stem cells (hESC growing on MEF feeder 
layer) 
• hESC medium was collected from the confluent hESC culture dish into a 15ml 
falcon tube.  
• 1ml of Dispase (4U/ml) was added to the culture dish and incubated for 10 
min at 37°C in the incubator (incubation time could change according to the 
enzyme activity, so care was taken to not to over digest). 
• The culture dish was tapped gently to detach the colonies from MEF and 
neutralized the dispase by adding 4ml of hESC medium collected in the first 
step. 
• All the colonies were collected into a 15 ml falcon tube and let it wait till all the 
cells sink to bottom of the tube.  
• Supernatant was aspirated and again washed the cells with 5 ml of hESC 
medium and let the cells to sink down. 
• Supernatant was aspirated and 1 ml. of Accutase was added along with 
ROCK inhibitor (10µM) and kept in 37°C water bath for 4 min. 
• With p1000 pipette, colonies were triturated for 15-20 times and observed for 
single cells under microscope. 
• Neutralized the accutase by adding 10 ml of hESC medium and centrifuged at 
1400 rpm for 5 min. 
• Aspirated the supernatant and again washed with ½ KSR + ¼ N2 + ¼ NB 
medium and ROCK inhibitor (10µM) and centrifuged at 1400 rpm for 5 min. 
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• Aspirated the supernatant, resuspended the pellet in ½ KSR + ¼ N2 + ¼ NB 
medium with ROCK inhibitor (10µM) and counted the cells with 
haemocytometer. 
• Plated 750K cells per each well of a 6-well low-attachment plate in 2 ml of ½ 
KSR + ¼ N2 + ¼ NB medium + ROCK inhibitor (10µM) + B27-RA (1%) and 
kept the plates in incubator at 37 oC and 5% CO2. 
• Day 0 media: ½ KSR+ ½ (N2+NB) medium + ROCK inhibitor (10µM) + B27-
RA (1:100) 
 
For Feeder independent pluripotent stem cells (iPSC growing on matrigel 
coated plates) 
• mTESR1 medium was aspirated from the confluent iPSC culture dish and 
washed the cells once with 3 ml of EDTA and aspirated out.  
• 1ml of EDTA was added to the culture dish and incubated for 3-4 min at 37°C 
in the incubator. 
• EDTA solution was aspirated gently without disturbing the colonies and added 
2 ml of accutase and kept back in the incubator for another 3 min.  
• Detached the colonies with 2 ml of mTESR1 and then transferred the 4 ml to 
a 15 ml falcon and triturated them and observed under microscope for single 
cells and then added 2 ml of mTESR1 medium. 
• Centrifuged the cells at 270g for 5 min. 
• Supernatant was aspirated and washed with 4 ml of ½ KSR+ ½ N2+NB 
medium with ROCK inhibitor (10 µM) and centrifuged at 270g for 5 min.  
• Supernatant was aspirated and resuspended the cells in 3 ml of ½ KSR+ ½ 
N2+NB medium with ROCK inhibitor (10 µM) and cells were counted. 
• Plated 750K cells per each well of a 6-well low-attachment plate in 2 ml of ½ 
KSR + ¼ N2 + ¼ NB medium + ROCK inhibitor (10 µM) + B27-RA (1%) and 
kept the plates in incubator at 37 oC and 5% CO2.   








• EBs were allowed to form and in order for them to not attach to plate, each 
well was scrapped using cell scraper gently 
• For day 3 EB transfer, New 6 cm dishes were coated ahead with 2ml of 
polyornithine/DPBS solution (15 µg/ ml polyornithine) -- 2 X 6 cm dishes were 
coated for each well of 6-well plate 
 
Day 2 
• EBs were scraped and collected in a 15ml falcon and waited for 15 mins for 
them to settle down. Centrifuged for 1 min at 200rpm and made sure whether 
the supernatant is clear and all EBs were settled down 
• Supernatant was aspirated and then resuspended the EBs in 2ml of day 2 
medium with inhibitor molecules SB-431542 (10 µM), Noggin (250 ng/ml) and 
XAV939 (3.3 µM) as required and replate the EBs in same wells. EBs were 
either untreated (denoted as Inhibitor-free), or treated with SB-431542 and 
Noggin (denoted dual SMAD-i), or treated with XAV-939 (denoted WNT-i), or 
their combination (denoted Triple-i). 
• Washed the PO plates prepared on Day1 with PBS twice and again coated 
with Fibronectin (1 µg/ml) and Laminin (1 µg/ml). 
Day 2 medium: ¼ KSR+3/4 (N2 + NB) + Rock inhibitor (10 µm)+ 1:100 B27-RA 
 
Day 3 
• Laminin plates were dried using 2 ml pipette encircling on the edges of the 
plate ( Just make 1 big drop) 
• EBs were scraped in each well using cell scraper, collected and distributed to 
2 X 6 cm plates. 
• Plates were kept for 10 mins in the incubator for the EBs to attach and then 
day 3 media was added. 
• Medium was not changed for next 4 days. 






Day 7  
• Medium was changed with ½ N2 + ½ NB medium along with inhibitor 
molecules SB-431542 (5 µM), Noggin (125 ng/ml) and XAV939 (3.3 µM)  
 
Day 9  
• Medium was replaced, all inhibitors were omitted and replaced with ½ N2 + ½ 
NB + FGF8 (100ng/ml) + BDNF (5ng/ml) + B27-RA (1%) 
 
Rosettes were allowed to form till day 12, following which cells were fixed, harvested 
for analysis, or subjected to terminal differentiation. Neural induction and direct 
rosette formation could be also obtained by adherence on Matrigel-coated plates as 
previously described [127], with the modifications defined for this study (such as 
XAV-939 addition etc.). Long term propagation of cortical neural progenitors was 
performed by a weekly mechanical harvesting of rosettes followed by re-plating on 
Po/Lam/FN coated dishes and culture with ½ N2 + ½ NB medium containing 1% B27 
without retinoic acid and with either FGF8 and BDNF (till day 28), or 20ng/ml of 
FGF2, EGF and BDNF (day 28 and on).  
 
2.8 Derivation of cerebral organoids from human pluripotent stem cells  
Organoids derivation was performed according to the Lancaster et al. protocol [170] 
with slight modifications as following. 
  
Day 0 
For Feeder dependent pluripotent stem cells (hESC growing on MEF feeder 
layer) 
• hESC medium was collected from the confluent hESC culture dish into a 15ml 
falcon tube.  
• 1ml of Dispase (4U/ml) was added to the culture dish and incubated for 10 
min at 37°C in the incubator (incubation time could change according to the 
enzyme activity, so care was taken to not to over digest). 
• The culture dish was tapped gently to detach the colonies from MEF and 




• All the colonies were collected into a 15 ml falcon tube and let it wait till all the 
cells sink to bottom of the tube.  
• Supernatant was aspirated and again washed the cells with 5 ml of hESC 
medium and let the cells to sink down. 
• Supernatant was aspirated and 6 ml. of trypsin was added along with ROCK 
inhibitor (10 µM) and kept in 37°C water bath for 4 min. 
• With p1000 pipette, colonies were triturated for 5 times and neutralized with 6 
ml of trypsin inhibitor and triturated again for 10 times and observed for single 
cells under microscope. 
• Washed twice by adding 10 ml of hESC medium + FGF2 (4 ng/ml) and 
centrifuged at 1400 rpm for 5 min. 
• Aspirated the supernatant and cell pellet was resuspended in hESC medium + 
FGF2 (4 ng/ml) + ROCK inhibitor (50 µM) and counted the cells. 
• Plated 9000 cells in 150 µl of hESC medium + FGF2 (4 ng/ml) + ROCK 
inhibitor (50 µM) per each well of a 96-well U-bottom low-attachment plate 
and kept the plates in incubator at 37 oC and 5% CO2. 
 
For Feeder independent pluripotent stem cells (iPSC growing on matrigel 
coated plates) 
• mTESR1 medium was aspirated from the confluent iPSC culture dish and 
washed the cells once with 3 ml of EDTA and aspirated out.  
• 1ml of EDTA was added to the culture dish and incubated for 3-4 min at 37°C 
in the incubator. 
• EDTA solution was aspirated gently without disturbing the colonies and added 
2 ml of accutase and kept back in the incubator for another 3 min.  
• Detached the colonies with 2 ml of mTESR1 and then transferred the 4 ml to 
a 15 ml falcon and triturated them and observed under microscope for single 
cells and then added 2 ml of mTESR1 medium. 
• Centrifuged the cells at 270g for 5 min. 
• Supernatant was aspirated and washed twice by adding 10 ml of hESC 
medium + FGF2 (4 ng/ml) and centrifuged at 270g for 5 min. 
• Aspirated the supernatant and cell pellet was resuspended in hESC medium + 
FGF2 (4 ng/ml) + ROCK inhibitor (50 µM) and counted the cells. 
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• Plated 9000 cells in 150 µl of hESC medium + FGF2 (4 ng/ml) + ROCK 
inhibitor (50 µM) per each well of a 96-well U-bottom low-attachment plate 
and kept the plates in incubator at 37 oC and 5% CO2. 
 
Day 1 
• Checked the plate under microscope and observed that EBs were started to 
form at the center of the plate along with some single cells surrounding the EB 
 
Day 2 
• 75 µl of medium was gently aspirated without disturbing the EB at the center 
and 150 µl of fresh hESC medium was added with inhibitor molecules SB-
431542 (10 µM), Noggin (250 ng/ml) and XAV939 (3.3 µM). Continued adding 
FGF2 (4 ng/ml) and ROCK inhibitor (50 µM) until the size of the EBs were 
around 350-400 µm in diameter. EBs were either untreated (denoted as 
Inhibitor-free), or treated with SB-431542 and Noggin (denoted dual SMAD-i), 




• Organoid size was measured under microscope. If the organoid size is above 
350um, FGF2 and ROCK inhibitor were not supplemented to the medium. 
• From each well, 150 µl of medium was gently aspirated and 150 µl of fresh 
hESC medium was added with inhibitor molecules SB-431542 (10 µM), 
Noggin (250 ng/ml) and XAV939 (3.3 µM). 
 
Day 6 
• Organoid size and morphology was checked under microscope. If the 
organoid size is greater than 400 µm and have brighter and smooth edges, 
then they were transferred to N2 neural induction medium. If the organoids 
were smaller in size, this step should be postponed for one day.  
• 500 µl of N2 medium supplemented with the inhibitor molecules (SB-431542 
(10 µM), Noggin (250 ng/ml) and XAV939 (3.3 µM)) were pre-added to each 
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well of 24 well low attachment plates and then kept in incubator at 37 oC for 
15-20 minutes. 
• Using clipped 200 µl pipette tip, organoids were transferred from each well of 
96 well plate to each well of 24 well plates with neural induction medium (one 
organoid per well). 
 
Day 8 
• 300 µl of media was aspirated from each well, and 300 µl of fresh medium, 
(similar to day 6 medium), was added to each well of 24 well plate.  
 
Day 10 
• 300 µl of media was aspirated from each well, and 300 µl of fresh medium, 
(similar to day 6 medium), was added to each well of 24 well plate.  
• Organoid size and morphology was checked under microscope. Observed 
organoids were brighter on the outside and began to show radial organization 
of pseudostratified epithelium indicating formation of neuroepithelium.  
 
Day 11 
• Matrigel was thawed on ice for about 1 hour for making matrigel droplets. 
• Parafilm was cut and sterilized with ethanol and dimples were made using 
empty 200 µl tip box tray. 
• Organoids were transferred into parafilm dimples by looking under the 
microscope using a clipped 200 µl pipette tip. Excess media was aspirated 
very gently and 30 µl of matrigel was added on top of each organoid and were 
gently pushed into the center of matrigel drop with a 10 µl tip to ensure 
complete embedding.  
• Organoids were then kept in incubator at 37 oC for 30 minutes and once the 
matrigel was solidified (gel), gently transferred using spatula into low 
attachment 6-well plate with N2 + NB + B27-RA (1%) medium. 4 organoids 







• Checked the organoids under microscope and neuroepithelial vesicle 
outgrowths were started to appear. Differences between different inhibitor 
conditions were obvious at this stage. 
 
Day 13 
• 1.5 ml of media was aspirated carefully without touching the organoids within 
in the matrigel droplets and then 1.5 ml of fresh media (similar to day 11 
medium) was added. 
 
Day 15 
• 1.5 ml of media was aspirated carefully and then 1.5 ml of fresh media now 
with 1% B27+RA (containing retinoic acid) was given. Plates were now 
transferred to an orbital shaker shaking with 86 rpm.  
• For long term organoid culture, medium was changed every 2 days. 
Organoids were fixed in 4% paraformaldehyde, 0.15% picric acid for 20-40 
minutes (RT) depending on their culture age, and then cryoprotected and 
processed as described under Immunostaining and confocal imaging section. 
 
2.9 RNA isolation 
RNA was isolated using the miRNeasy™ RNA Mini Kit (Qiagene) according to the 
manufactures protocol briefed below.  
• 700 µl of QIAzol lysis reagent was added to the sample and were vortexed for 
1 min to get a homogenized mixture.  
• Homogenate was then incubated at room temperature (15-25 oC) for 5 min. 
• 140 µl of chloroform was added and shaked vigorously for 15s and incubated 
at room temperature for 2-3 mins and centrifuged for 15 mins at 12000g at 
4oC. 
• Sample forms an organic and aqueous phase after centrifugation. 300 µl of 
aqueous phase was collected without touching the organic phase and 
transferred to a new collection tube and 450 µl of 100% ethanol was added 
and mixed thoroughly by pipetting up and down. 
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• 700 µl of sample was transferred into RNeasy mini column placed in a 2 ml 
collection tube. Centrifuged at 8000g for 15 s at room temperature and flow 
through was discarded.  
• 350 µl of buffer RWT (prepared with isopropanol) was added into the RNeasy 
mini spin column and centrifuged for 15s at 8000g and flow through was 
discarded. 
• 10 µl of DNase I stock solution was added to 70 µl of buffer RDD and mixed 
gently by inverting the tube. 
• DNAse I incubation mix (80 µl) was pippeted directly onto the RNesay mini 
spin column membrane and incubated for 15 min at room temperature. 
• 500 µl of RWT buffer (prepared with iso-propanol) was added into RNeasy 
mini spin column and centrifuged for 15 s at 8000g. Flow through was kept 
and reapplied into the RNeasy mini spin column and centrifuged again at 
8000g for 15 sec. Flow through was discarded. 
• 500 µl of RPE buffer was added to RNeasy mini column. Centrifuged for 15 
sec at 8000g. Discarded the flow through. 
•  Again 500 µl of buffer RPE was added to the column and centrifuged for 2 
min at 8000g. Discarded the flow through. 
• Transferred the RNeasy mini columns to a new 1.5 ml collection tube and 
eluted the RNA in 30 µl of RNase free water. 
• Eluted RNA quality and concentration was measured using nanodrop. 
 
2.10 Preparation and Sequencing of RNA-Seq Libraries 
RNA-seq libraries for human samples were generated using the Illumina TruSeq 
RNA Library Preparation Kits, and pooled sampled were sequenced on the Illumina 
HiSeq 2500 sequencer as 100bp paired-end reads.  
 
2.11 Description of processed RNA-Seq datasets of human brain 
transcriptomes  
Gene expression data for different brain regions was retrieved from BrainSpan Atlas 
of the Developing Human Brain (http://human.brain-map.org/) based on extensive 
RNA-Seq study done by Šestan and colleagues [171]. Among the samples collected 
for that study, for our analysis we utilized datasets obtained from 16 brain regions 
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dissected from 8 to 37 gestational weeks, out of which 11 obtained from different 
neocortical regions and 5 others collected from the hippocampal primordia (future 
hippocampus), sub-cerebral regions including the diencephalon (future thalamic 
structures) and the sub-pallium (future striatum), as well as posterior brain regions 
(cerebellum). The file “RNA-Seq Gencode v10 summarized to genes” containing 
RPKM values (available at http://www.brainspan.org/static/download.html) was 
downloaded on 3.08.2017. A detailed description of data processing procedures for 
generating the above file by the authors is available at (http://help.brain-
map.org/display/devhumanbrain/Documentation). 
 
2.12 RNA-Seq data processing and normalization for single and pooled 
organoids 
Raw RNA-Seq reads were mapped to the human reference genome hg19 using 
STAR mapper [172]. Generated bam files were filtered for uniquely mapped reads 
using Samtools [173] and read counts were generated using HTSeq [174] 
(parameters: -m intersection-strict --nonunique all -r pos -s reverse). For further 
analysis, all mitochondrial genes were removed from the data. RPKM values were 
calculated by dividing the number of counts by gene length and sequencing depth, 
followed by multiplying by 10E9. For data normalization, only RefSeq-annotated 
genes were considered and their RPKM values were normalized by bringing the 
samples to the same RPKM sum. For generating heatmaps, a pseudocount of 1 was 
added to RPKM values, and a log2 base was then taken. Afterwards, all rows 
(genes) of heatmap matrices were scaled to a range (-0.5, 0.5). 
 
2.13 Combined RNA-Seq data analysis for organoid and human brain datasets 
Since raw RNA-Seq datasets for human brain regions have not been accessible, 
combined comparative analysis of BrainSpan and cerebral organoid samples 
together was re-processed so as to minimize the processing differences between 
both datasets. This was achieved first by re-processing organoid datasets similar to 
as described above for processing organoid datasets alone, such that HTSeq 
parameter -s was changed to “no”. In addition, all values generated by merging both 
RPKM matrices were quantile normalized. To remove non-biological variations 
revealed by the correspondence analysis (see description below), the function 
ComBat [175] from the sva package [176] was applied. ComBat uses an empirical 
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Bayesian framework to adjust data for batch effects and other unmeasured sources 
of variation. 
 
2.14 Correspondence analysis 
Correspondence analysis (CA) [177] is a projection method that represents variables 
such as expression values of genes as vectors in a multidimensional space. Similar 
to principal component analysis (PCA), CA reveals also principal axes of the 
investigated space. This allows projecting data matrix into a low-dimensional 
subspace, thereby investigating the main variance in the data. Moreover, in contrast 
to PCA, CA can simultaneously account for samples in a gene-dimensional space 
and for genes in a sample-dimensional space - showing the information in a so-
called biplot. The interpretation of CA biplot is such that one finds the genes 
characteristic for a (group of) sample(s) in the direction of this sample (group). The 
farther away from the center the genes lie, the more characteristic they are for the 
respective sample(s). 
 
Both correspondence analyses from our study were conducted using the 10,000 
genes with the highest expression variance across investigated samples. In the 
combined analysis of brain and organoid samples, we first merged both RPKM 
matrices and projected the new matrix into the three-dimensional subspace. The 
resulting CA plot shows very clearly that the first principal axis accounts for the 
technical variation between both datasets (data not shown). Hence, to remove the 
observed bias we applied ComBat, and the result of the final CA of the ComBat-
transformed data is shown in Figure 12.  
 
2.15 Differential Expression and Gene Set Enrichment analysis between 
organoids 
From the Allen Brain Atlas dataset, we estimated markers for different brain regions 
during weeks 12-21, by comparing the log2 fold change of the raw RPKM expression 
in each regional sample compared to all other regions across weeks 12-21.  Genes 
were defined as regional-specific if they had at least a log2 fold change of 2 when 
compared to all other regions, excluding striatal and amygdala samples, across all 
weeks.  We furthermore filtered striatal and amygdala specific genes by removing 
genes with a log2 fold change of 2 in amygdala or striatal samples compared to all 
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other regions across weeks 12-21.  To determine differential gene expression across 
brain organoids derived by different protocols, we ran DeSeq2 [Love et al., 2014] on 
three pairwise treatment comparisons, Triple-i vs Dual-SMADi, Triple-i vs Inhibitor-
free, and Dual-SMADi vs Inhibitor-free, using 8 biological replicates of individual 
organoids from each protocol.  Regional genes derived from the Allen Brain Atlas are 
subsequently highlighted in the volcano plot.  A Gene Set Enrichment Analysis 
(GSEA) [citation] was then run to determine enrichment of the regional specific gene 
sets in each of the three comparisons. Furthermore, among we estimated z-scores 
of the expression in the Allen Brain Atlas. 
 
2.16 Single cell RNA-Seq procedures 
2.16.1 Organoid dissociation 
D50 organoids (N=4) derived by different treatments were dissociated into single 
cells using papain dissociation kit (Worthington). Organoids were first incubated with 
papain and DNase I solution for 35 min and then triturated and filtered through 40-
micron filter to obtain single cell suspension. Cells were centrifuged at 300g for 5 
min, re-suspended in Hank’s Balanced Salt Solution (HBSS), counted for viability 
(>80% were viable) and FACS sorted using FACS Aria III (Becton Dickinson), while 
excluding dead cells labeled with DAPI.  
 
2.16.2 Single cell library preparation 
Roughly 50,000 single organoid derived and sorted live cells were collected in PBS 
buffer (100 cells/µL) and subjected to an inDrop procedure [178, 179]. Briefly, 
collected cells were injected in the commercially available inDrop™ system from 
1CellBio. Hydrogel bead-cell co-encapsulation, in-drop synthesis of barcoded cDNA 
and library preparation was performed according to the recommended procedures of 
the manufacturer. Obtained libraries were sequenced using Illumina short read 
sequencing.  
 
2.16.3 Single cell RNA-Seq data processing 
Two paired-end sequencing batches were generated using a NextSeq 500 
sequencing device (Illumina). These two batches were treated separately until the 
dataset alignment was performed by applying the Seurat pipeline (Andrew et al, 
bioRxiv 2017). The alignment step described below is important to correct any 
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potential batch effects and normalize the data altogether. The sequencing data was 
converted to fastq by fastq-dump (v2.4.5) using default parameters. Read 1 was 
used to obtain the sample barcode and UMI (unique molecular identifiers) 
sequences; read 2 was then mapped to a reference transcriptome as described 
below. The reads were first filtered based on presence in read 1 of two sample 
barcode components separated by the W1 adaptor sequence. Read 2 was then 
trimmed using Trimomatic (Bolger et al., 2014) (version 0.36; parameters: 
LEADING:28 SLIDINGWINDOW:4:20 MINLEN:16). Barcodes for each read were 
matched against a list of the 3842 pre-determined barcodes from 1CellBio, and 
errors of up to two nucleotides mismatch were corrected. Reads with a barcode 
separated by more than two nucleotides from the reference list were discarded. The 
reads were then split into barcode specific files for mapping and UMI filtering. We 
kept barcodes with minimum 10000 UMIs.  
 
2.16.4 Single cell gene mapping and UMI counting  
The UMI alignment was done according to [180]. In summary, reads split into 
barcode-specific files were aligned using Bowtie (version 0.12.0, parameters: -n 1 –l 
15 –e 300 –m 200 –best –strata -a) to the human transcriptome. Alignments from 
bowtie were filtered in order to choose the alignment closer to the end of the 
transcript. The resulting UMI counts tables were concatenated and loaded into R for 
analysis. Cells with less than 5000 mapped UMIs and less than 500 detected genes 
(at least one UMI) were discarded. 
 
2.16.5 Single cell dataset alignments, tSNE analysis and cell-subpopulation 
identification 
The UMI counts tables were then merged across all cells in organoids derived by 
Triple-i, dual-SMAD-i, and Inhibitor-free treatments. First, the counts were divided by 
the library size (number of UMIs in each cell) and then multiplied by a scaling factor 
of 10000, and log(x+1) transformed, using Seurat’s “NormalizeData” function. The 
scaled z-score residuals were then estimated after regressing on the number of UMI 
and percent of mitochondrial counts per cell using Seurat’s “ScaleData” function. 
Principal Component Analysis was then performed on the scaled z-score residuals of 
the most highly variable genes (log variance to mean ratio of UMI counts at least 
0.5), 2868 genes in total. Clusters were determined using the graph-based clustering 
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approach “FindClusters” in Seurat on the first 6 principal components from PCA with 
a resolution of 0.6. The tSNE visualization was then generated using the first 10 
principal components.  
 
2.17 Immunostaining and confocal imaging 
Cells were fixed in 4% paraformaldehyde, 0.15% picric acid, permeabilized and 
blocked with PBS, 1% bovine serum albumin (BSA), 10% FBS and 0.3% Triton 
solution. Organoids were similarly fixed, washed, cryoprotected with 30% sucrose 
overnight and then submerged in OCT. Fixed cells or sectioned organoids (10uM 
slices) were stained with indicated primary antibodies (see below) followed by Alexa 
Fluor secondary antibodies (Invitrogen). Following staining, cells were imaged in 
PBS, and organoid sections were mounted on Moviol (Sigma). Fluorescence images 
were obtained using a confocal microscope LSM710 (Carl Zeiss Micro Imaging, 
Germany). The confocal images were captured using 10X and 20X objectives 
(NA=0.3 and 0.8, Plan-Apochromat, respectively). Fluorescence emissions resulting 
from Ar 488, 543 and 633 nm laser lines for EGFP, CY3 and CY5, respectively, were 
detected using laser scanning settings and filter sets supplied by the manufacturer. 
For DAPI detection in all images as well as GFP detection for organoid images, we 
used our mode-locked Ti:Sapphire, fento second pulsed, multiphoton laser 
(Chameleon Ultra II, Coherent, Inc.) at a wavelength of 720 nm and 920 nm, 
respectively. Epi fluorescent and phase contrast images were obtained using Nikon 
Eclipse Ti-E microscope. Fluorescence emissions results from mercury arc lamp. 
Images were taken using 10X and 20X objectives. Images were generated and 
analyzed using either Zeiss ZEN 2011 software (Carl Zeiss, Inc.) or NIS elements 
software (Nikon). All images were exported in TIF and their color levels were 
identically adjusted per each staining procedure. 
 
2.17.1 Table for antibodies list 
 
Antibody name Vendor Dilution 
CTIP2 ABCAM (ab18465) 1:250 
CUX1 ABCAM (ab54583) 1:200 
CUX2 ABCAM(ab130395) 1:100 
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EMX2 ABCAM(ab94713) 1:50 
FEZF2 ABCAM(ab69436) 1:250 
FOXG1 ABCAM(ab18259) 1:400 
p-VIMENTIN ABCAM(ab22651) 1:120 
PERICENTRIN ABCAM(ab4448) 1:1000 
SATB2 ABCAM(ab51502) 1:50 
NKX2.1 ABCAM(ab76014) 1:400 
SOX1  ABCAM 1:1000 
SOX2  ABCAM (ab79351), 1:500 
TBR1 ABCAM(ab31940) 1:500 
TBR2 ABCAM(ab23345) 1:200 
HOXB4 DSHB (concentrated)  1:100 
NKX2.2 DSHB(74.5A5,concentrated) 1:120 
PAX6 DSHB(concentrated) 1:22 
GAD65 R & D (AF2247) 1:40 
OTX2 R & D(AF1979) 1:40 
SOX1 R & D(AF3369) 1:40 
SOX17  R & D(AF1924) 1:30 
TUJ1  BD Biosciences (560340) 1:500 
COUP-TF1  Millipore (ABE1425) 1:500 
DCX Millipore (AB2253) 1:500 
RELN Millipore(MAB5364) 1:200 
β-3-Tubulin Covance (PRB-435P) 1:500 
FOXA2 Santa cruz biotechnology 
(SC-6554) 
1:100 
PTPRZ1 Sigma (HPA015103) 1:500 
SP8 Atlas Antibodies 
(HPA054006) 
1:50 
CAS-3 Cell signaling (#9661) 1:500 
GFAP Dako 1:1000 
Poly-Glutamylated 
TUBULIN 




2.18 Quantitative PCR (qPCR) analysis 
RNA was extracted using miRNeasy kit (Qiagene) followed by cDNA reverse 
transcription kit (Applied Biosystems). 4-6ng of cDNA was subjected to qPCR using 
our homemade designed primers (see ‘Primer set list’), FastStart universal SYBR 
green (Roche) and ViiA-7cycler (ABI). Threshold cycle values were determined in 
triplicates and presented as average relative fold over those of HPRT. Fold changes 
were calculated using the 2-Δct method. 
 







CUX1_F 5′- CAACAAGGAATTTGCTGAAGTG -3′ 
CUX1_R 5′- CTATGGTTTCGGCTTGGTTC -3′ 
CUX2_F 5′- GAGCTGAGCATCCTGAAAGC -3′ 
CUX2_R 5′- AGGCCTCCTTTGCAATAAGC -3′ 
DCX_F 5’-CATCCCCAACACCTCAGAAGA -3’ 
DCX_R 5’-CGTTTGCTGAGTCAGCTGGA-3’ 
EGFR_F 5′- GATAGTCGCCCAAAGTTCCGT -3′ 
EGFR_R 5′- CTGAATGACAAGGTAGCGCTG -3′ 
FEZF2_F 5’-CCCAGGAAAAGCCACATAAAT-3’ 
FEZF2_R 5’-GGATGCGGATATGCGTGTT-3’ 




GFAP_F 5′- AGAGATCCGCACGCAGTATG -3′ 













S100β_F 5′- GGAAATCAAAGAGCAGGAGGTT -3′ 
S100β_R 5′- TCCTGGAAGTCACATTCGCC -3′ 
SATB2_F 5′- TAGCCAAAGAATGCCCTCTC -3′ 











2.19 Measurements and statistical analysis 
For all qPCR gene expression analysis obtained for neural induction, cortical 
specification, and iPSC characterization experiments, two-way ANOVA test followed 
by Tukey’s multiple comparison test were applied. Statistical analysis was performed 
using GraphPad software. For calculating organoid size, as well as neuroepithelial 
and luminal measurements (area, perimeter and luminal length) ImageJ or Nis-
elements (Nikon) software was used. For neuroepithelium area calculation, luminal 
areas were subtracted from entire vesicle areas. For all size organoid/vesicle size 
measurements, for SOX2/DCX counting in organoids and rosette derived 
progenitors, and for P-VIM nuclei counting, t-Test was applied. Statistical analysis 





3.1 Neural induction platforms 
We used PSC based two neural differentiation platforms – neural rosettes grown as 
2D monolayer cultures and brain organoids grown as 3D cultures. We have used 
both hESC (HES5::eGFP hESC reporter line – in order to assess notch activation 
status) and hiPSC line (ZIP8K8 iPSC line– as an additional supporting cell line to 
confirm the results observed in hESC) and subjected these to 2D and 3D neural 
differentiation methods. In the case of 2D culture, we first modified a standard 
embryoid body (EB) protocol to generate small EBs formed by aggregation period of 
3 days and followed by attachment and continued differentiation as 
monolayer/flattened adherent colonies on laminin coated plates. We reasoned that 
small EBs generated by short aggregation should combine preservation of early cell-
to-cell mediated intrinsic inductive signaling together with maximized responsiveness 
to exogenous cues once they were flattened. This is in contrast to 3D systems, 
where intrinsic inductive signals are sufficient to enable self-organization ability of 
neuroepithelial cells into CNS fates (Lancaster et al., 2013). To compare the different 
inhibition paradigms on both systems, we employed inhibition-free conditions 
(denoted as Inhibition-free), WNT inhibition alone using XAV 939 (WNT-i), TGF-β 
and BMP inhibition using SB-431542 and Noggin (dual SMAD-i) (Chambers et al., 
2009), and combined dual SMAD-i and WNT-i (Triple-i).  
 
We employed these inhibitors starting on day 2 of differentiation, when EB formation 
was evident and continued till day 9. While dual SMAD-i is known to strongly induce 
CNS specification, WNT-i impairs early gastrulation events [181, 182] during early 
differentiation phases (days 2-5), and thus streamline dual SMAD inhibition-mediated 
CNS specification. Continued WNT inhibition through the neural induction period 
(days6-9) should allow preferential expansion of anterior neuroectodermal fates on 
the expanse of caudal fates during the neural patterning phase [53, 183]. WNT 
inhibition was omitted on day 9 prior to robust Notch activation [127] so as to allow 
cortical progenitors to utilize endogenous WNT activation required for their 
maintenance, once established [184, 185, 186]. In 2D system, inhibitor withdrawal on 
day 9 was complemented by addition of FGF8 for the proliferation of NE cells. In 
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case of 3D organoids, we followed the inhibitor-free method of Lancaster et al., [129] 
on top of which inhibitors were added from day 2 like in the 2D system and continued 
till neural induction period i.e., till the day of Matrigel embedding (day11-12). 
Following inhibitor withdrawal, organoids were supplemented with B-27 without 
retinoic acid till day 15 and then transferred to a moving orbital shaker for more 






















Figure 10: Differentiation scheme  
Schematic showing generation and maintenance of 2D monolayer neural rosettes (above) and 3D 
cerebral organoids (below) from human pluripotent stem cells. 
 
3.2 Molecular analysis of 3D organoids and 2D neural rosettes generated 
under different inhibition paradigms 
 




We assessed the transcriptional signature of neural progenitors derived by various 
inhibitory paradigms under both 2D monolayer cultures and brain organoids grown 
as 3D cultures. We employed RNA-Seq on multiple, individually processed day 30 
organoids (N=8) derived by either inhibitor-free, dual SMAD-i or Triple-i conditions. 
We also analyzed day 17 (N=3) and day 30 (N=3) organoids that were pooled and 
processed together. Correspondence analysis (CA) first confirmed that 
undifferentiated PSCs, day 17 organoids and day 30 organoids segregated as 
separate clusters, reflecting expected differences in general transcriptional identity 
during the transition from the undifferentiated state towards early and then later 
neural stages (Figure 11). Remarkably, while day 17 organoids appeared proximal to 
each other regardless of treatment, day 30 organoids further sub-segregated into 
three sub clusters corresponding to the three derivation paradigms, demonstrating 
that making organoids by different methods clearly creates distinct transcriptional 




Figure 11: Correspondence analysis (CA) plot of 3D organoid RNA-Seq datasets  
Correspondence analysis (CA) plot of RNA-Seq datasets obtained from undifferentiated PSCs (D0), 
day 17 organoids (D17) and day 30 organoids (D30) derived by indicated treatments. Transcriptome 
profiles were obtained from single, individually processed (N=8) D30 organoids, pool (≥3) processed 
D17 organoids and pool (≥3) processed D30 organoids derived under indicated treatments. Symbols: 
diamonds represent PSCs (Grey), inhibitor-free organoids (Yellow); dual SMAD-i derived organoids 
(Red), Triple-i derived organoids (Orange) and WNT-i derived organoids (Pink). P: Pooled organoids. 
-/- and +/-: homozygous and heterozygous microcephaly mutant organoids (discussed in detail under 
microcephaly result section). 
 
3.2.2 Comparative correspondence analysis of organoid RNA-Seq profiles and 
human brain samples reveals substantially distinct human brain signatures 
To gain a comprehensive look into the brain regions assigned by the differently 
derived organoids we integrated transcriptional datasets from the Allen Human Brain 
Atlas (http://human.brain-map.org/) done by Šestan and colleagues [171] in to 
organoid CA plots (Figure 11). For our analysis we utilized datasets obtained from 16 
brain dissected regions from 8 to 37 gestational weeks, out of which 11 samples 
were obtained from different neocortical regions and 5 others collected from the 
medial pallium (future hippocampus), sub-cerebral regions including the 
diencephalon (future thalamic structures) and the sub-pallium (future striatum), as 
well as more posterior brain regions (cerebellum). These integrated CA plots showed 
first that embryonic brain samples clustered into three distantly located gestational 
week groups corresponding to week-8, weeks 12,16,21, and week-37. Yet, each 
cluster contained representatives of all forebrain sub-structures tested, (neocortical, 
hippocampal, sub-cerebral) excluding hindbrain regions, which clustered elsewhere 
than cortical regions (Figure 12). We interpreted this wide distribution of groups 
across developmental age as reflection for extensive transcriptional remodeling of 
forebrain/cortical cell identity and composition during development. Interestingly, day 
17 organoids derived by all methods overlapped with week-8 forebrain/cortical 
cluster. However, among the three sub clusters representing day 30 organoids 
derived by the different treatments, only Triple-i derived organoids overlapped with 
forebrain/cortical embryonic structures, with a particular overlap with week-21 
forebrain samples (Figure 12). These findings provide strong evidence that early 
exposure to combined dual SMAD and WNT inhibition (Triple-i) is critical for 







Figure 12: Correspondence analysis (CA) plot of 3D organoid RNA-Seq datasets integrated 
with human brain regional transcriptomic dataset  
CA plots calculated for RNA-Seq datasets obtained from (Figure 11) and then integrated with human 
brain region specific RNA-Seq datasets (Allen Human Brain Atlas: http://human.brain-map.org/) 
corresponding to 16 brain regions including 11 neocortical areas, hippocampus, ventral forebrain, 
diencephalon and cerebellum and collected across several developmental stages ranging from 
gestational week-8 to week-37. Symbols for organoid samples appear as in (Figure 11). Brain region-
specific samples appear as circles representing cortical regions (Turquoise) further sub-divided to 
frontal cortex (vertical crossing line), parietal cortex (horizontal crossing line), temporal cortex (vertical 
and horizontal crossing line) and occipital cortex (diagonally crossing lines), as well as hippocampus 
(light purple), diencephalon (green), hindbrain (blue) and ventral pallium (dark green). Each cluster 
was encircled by its respective color. See methods for further sub-divisions according to Šestan and 
colleagues [171]. Note the close proximity of the Triple-i derived D30 organoids to week-21 human 
neocortex/forebrain samples. Large scale cluster distribution appears at the bottom.  
 
While forebrain and hindbrain (cerebellum) structures well separated from each other 
in our CA plots, less separation between cortical, medial pallium or sub-cortical 
regions could be seen within the forebrain domain. We next identified biomarkers for 
the cortex, medial pallium, diencephalon, and cerebellum across weeks 12 through 
21 in the Allen human brain data sets. We then did a differential gene expression 
analysis on the pairwise comparisons of different treatments i.e., Triple-i vs dual 
SMAD-i (Figure 13A), Triple-i vs Inhibitor-free (Figure 13B) and dual SMAD-i vs 
Inhibitor-free (Figure 13C) to identify the genes enriched in each treatment. This 
analysis revealed that Triple-i significantly enriches for cortical genes (Figure 13A 
and 13B) whereas dual SMAD-i shows a significant enrichment of diencephalon and 
cerebellum specific genes (Figure 13A and 13C) while Inhibitor-free shows a slight 






























Figure 13: Differential gene expression and gene set enrichment analysis  
A. Volcano plot of day 30 Triple-i organoids vs dual SMAD-i organoids.  Log2 fold change is plotted 
on the x-axis and -log10 (Q-value) is plotted on the y-axis, estimated by DESeq2.  Significant 
differential expression (DE) of region-specific genes of weeks 12-21 measured in the Allen human 
brain atlas dataset are highlighted in the plot.  The distributions of significant DE regional genes are 
plotted in the violin plot beneath the volcano plot. The -log10(Q-value) after running a Benjamini-
Hochberg correction of Gene Set Enrichment Analysis using regional gene sets derived from Allen 
Brain Atlas samples from weeks 12-21 for day 30 Triple-i organoids vs dual SMAD-i organoids.  An 
asterisk is plotted at the peak of the bar to signify whether the GSEA test was significant using a Q-
value of 0.1. 
B. Volcano plot of day 30 Triple-i organoids vs Inhibitor-free organoids.  See (A) for plot description. 
C. Volcano plot of day 30 dual SMAD-i organoids vs Inhibitor-free organoids.  See (A) for plot 
description. 
 
We then compared the differentially expressed gene sets from the pairwise 
comparisons of day 30 organoids to the regional specific gene sets from weeks 12 
through 21 in in-vivo human brain data. Among the 206 cortex specific genes, 23 
were consistently upregulated in Triple-i organoids (upregulated in both Triple-i vs 
dual SMAD-i and in Triple-i vs Inhibitor-free) (Figure 14).  When overlaying the 
relative expression levels of these genes in the Allen Bran Atlas samples, we 
observe that the Triple-i specific gene set has the highest expression level, followed 
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by the 12 genes enriched in both dual SMAD-i and Triple-i. All together these 




















Figure 14: Differential gene expression and gene set enrichment analysis overlaid on Allen 
human brain regional biomarkers expression 
Venn diagrams of treatment specific DE genes and Allen human brain regions specific gene sets.  
Color of Venn diagram sections represents the relative expression levels of genes across Allen 
human brain samples from weeks 12-21, calculated by estimating mean expression level across all 
samples from the respective region across weeks 12-21, estimating mean of these values, and 
calculating z-score from this value across all sections.  Sections were only included with 5 or more 
genes present. 
 
One of the limitations of current organoid methods is the existence of high variability 
between the organoids generated in the same experiment. In order to identify the 
molecular heterogeneity between the organoids derived under different inhibition 
paradigms, we examined the expression of a panel of brain region characteristic 
markers such as dorsal pallium (neocortical), medial pallium (cortical 
hem/hippocampal primordia) and diencephalic (thalamic), as well as more posterior 
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regions such as mid-hindbrain – all across different treatments (Figure 15). We found 
that genes expressed in neocortical region, were predominantly and homogenously 
induced by most Triple-i organoids (Figure 15). Intriguingly, medial pallium genes 
corresponding to the cortical hem and hippocampal primordia could be induced by 
any of the methods, including inhibitor-free conditions, indicating that the formation of 
this forebrain/cortical organizer is largely unaffected by WNT activation (or inhibition) 
levels modulated in this study. Third, sub-cortical and more posterior brain regions 
including diencephalon, midbrain and hindbrain, were exclusively and also 
heterogeneously induced by dual SMAD-i. Finally, induction of these posterior fates 
by dual SMAD-i coincided with enhanced NSC marker expression. This was 
compatible with a similar trend in human week-21 brains [171] – the in vivo 
embryonic counterpart of day 30 organoids – where higher expression level of NSC 
markers such as HES5, NOTCH1, NES and SOX2 is observed for cerebellar 
structures, when compared to other brain parts. To conclude, our results show that 
different derivation methods result in distinct global transcriptional identities in 
organoids. Moreover, the findings also particularly pinpoint combined WNT-i on top 
of dual SMAD-i as critical for yielding cortical fates. Last, since inhibition was 
employed during early days of differentiation (until day 10), our findings also suggest 
that shaping the identity of the starting population by exogenous cues in early days is 
critical and sufficient for inducing a lasting cerebral fate induction effect also after 20 




Figure 14: Brain regions specific gene expression among organoids across defined treatments 
A heatmap representing expression values for selected genes categorized according to neural stem 
cell markers and additional groups of regional markers (neocortex, medial pallium, diencephalon and 
midbrain-hindbrain) in day 30 organoids derived under indicated treatments. Color-coded scale 
represents relative expression levels of each gene (row) across treatments. 
 
3.2.3 Correspondence analysis for RNA-Seq profiles of 2D neural rosettes 
derived by different methods 
The effects of inhibitors also worked similarly for 2D monolayer cultures despite the 
lack of certain cell-to-cell interactions and cytoarchitectural components required to 
efficiently recapitulate specification. CA plots generated for RNA-Seq obtained from 
day 8, 10 and 12 of monolayer cultures generated under different inhibitory 
paradigms (Figure 15A) reveals a clear distinction between dual SMAD-i and Triple-i 
derived samples on one hand, and WNT-i and inhibitor-free derived samples on the 
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other hand – segregating neural fate-favoring from -unfavoring conditions [121, 125]. 
Also, the differences between dual SMAD-i and Triple-i became greater as days 
progressed, with major change observed on day 12 of differentiation (Figure 15A). 
Consistently, differences in expression level of the same regional and NSC markers 
used to characterize organoids were most apparent between treatments on day 12 
(Figure 15B). In addition, we interestingly observed that anterior/cortical genes were 
expressed on day 8 under both dual SMAD-i and Triple-i, but then peaked on day 12 
under Triple-i, while declining under dual SMAD-i with concomitant upregulation of 
posterior/non-cortical genes. This was similar to reminiscent of studies in frogs 
where some anterior neural axis fates developed first, from which only later 
transformed to posterior fates [11, 12]. The upregulation of diencephalic and 
midbrain-hindbrain genes already on day 8 and consistently increased up to day 12 
in dual SMAD-i treatment demonstrates that the early starting populations generated 
were heterogeneous with both cortical and non-cortical fates (Figure 15). Notably, 
some posterior markers were upregulated on earlier days also under inhibitor-free 
and WNT-i conditions, possibly reflecting early non-neural fates marked by the same 
genes. This was not recorded in inhibitor-free or WNT-i derived organoids, which 
again, could develop neural fates in the absence of inhibitors. While trends for 
forebrain and diencephalic-mid-hindbrain patterning genes were generally similar for 
2D and 3D, medial pallium markers corresponding to the cortical hem/future 
hippocampus seemed to be induced by dual SMAD-i better than Triple-i, compared 
to the treatment-indifferent induction of this structure in organoids (Figure 15B). 
Nonetheless, these results still argue that also in 2D cultures Triple-i is critical for 






Figure 15: Correspondence analysis (CA) plot of 2D rosette RNA-Seq datasets generated 
under different treatments and their relative brain regions specific gene expression signature  
A) CA plots of RNA-Seq datasets obtained from day 8 (D8), day 10 (D10) and day 12 (D12) 
monolayer neural progenitors derived by indicated treatments. Same symbols as in organoids apply 
to monolayer samples. 
B)  A heatmap representing expression values for selected genes categorized as in (Figure 14) and 
obtained for day 8, day 10 and day 12 monolayer neural progenitors derived under indicated 
treatments. Color-coded scale represents relative expression levels of each gene (row) across 
treatments and days. 
 
3.3 Cellular analysis of 3D organoids and 2D neural rosettes generated under 
different inhibition paradigms 
 
3.3.1 Enhanced Notch activation and robust radial organization are hallmarks 
for transition of PSCs towards cortical fates 
The molecular analysis draw a clear dichotomy between the specification of distinct 
cortical and non-cortical (posterior) identities both in 2D and 3D systems based on 
the addition or exclusion of a single pathway inhibitor for WNT signaling (on top of a 
dual SMAD-i background). Nevertheless, as cortical stem cell markers can be 
somewhat unambiguous such as known SOX2, SOX1 and PAX6 markers are 
present in both cortical (neocortex) and non-cortical (diencephalon, mid/hindbrain) 
cell types, so one main concern is how to assess - already at the early neural 
starting population level - the efficiency of cortical differentiation. In search for such 
reliable readouts, based on evidence from our lab, we reasoned that Notch activation 
and radial organization (rosette formation) capacity - when overlapping - may serve 
as a potential readout for efficient early specification towards cortical identity. Our 
earlier studies showed that radial organization (rosette formation) of early 
telencephalic neural progenitor cells is abrogated in the presence of Notch signaling 
inhibitors [119]. We further coupled Notch activation and radial organization to 
cortical neurogenesis by showing that only cells obtained from mechanically isolated 
Notch active radially organized structures (i.e. rosettes) could give rise cortical 
neurons in a time and cortical layer dependent manner [127]. We also validated this 
correlation at the molecular level by revealing transcriptional and epigenetic factors 
associated with corticogenesis that drive Notch activation at the rosette stage [146]. 
Finally, we demonstrated that Notch active cells within rosettes performed 
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interkinetic nuclear migration – the hallmark phenomenon of cortical differentiation 
[147], and then used this feature as a cytoarchitectural quantitative readout for 
cortical differentiation at the rosette stage. 
 
Here we revisited the ability of Notch activation and radial organization to project 
cortical cell identity within starting populations. We used the same HES5::eGFP 
human embryonic stem cell reporter line [166] used for RNA-Seq to correlate Notch 
activation and radial organization capacity to cortical fate specification in 2D and 3D 
systems. In 2D cultures, Notch activation (HES5::eGFP expression) and rosette 
formation were completely absent from inhibitor-free and WNT-i derived progenitors, 
observed to some extent and not necessarily overlapping in dual SMAD-i derived 
progenitors, and were both highly enhanced in Triple-i derived progenitors (Figure 16 
A). However, in addition to their enhancement under Triple-i conditions, they 
impressively overlapped (Figure 16A), suggesting a strong link between efficient 
radial organization and Notch activation cellularly, and the acquisition of cortical fates 
transcriptionally. 
 
In organoids on the other hand, the generation of vesicle-like neuroepithelial 
protrusions – a 3D counterpart of rosettes -were naturally occurring under all 
treatments (Figure 16B), in line with other studies [129, 131-133, 136]. However, 
under inhibitor-free organoids, radially organized structures exhibited weak Notch 
activation through entire organoid sections in multiple organoids (N=9) (Figure 16B), 
suggesting attenuated stemness. In correlation, inhibitor-free organoids developed 
non-neuroepithelial extensions similar to previous observations [129]. WNT-i alone 
increased radially organized protrusions in organoids (N=9), improved their Notch 
activation, and eliminated non-neuroepithelial extensions (Figure 16B). This was in 
contrast to the poor ability of WNT-i alone to drive Notch activation or radial 
organization in monolayers (Figure 16A), emphasizing the potential of 3D systems to 
utilize a WNT-depleted cellular environment to streamline self-acquisition of neural 
fates. Nonetheless, radial organization in organoids derived by WNT-i often 
remained in a small scale, and Notch activation was not first-rate (see HES5::eGFP 
images for Triple-i). In correlation, WNT-i derived organoids were transcriptionally 
heterogeneous (Figure 11), and often did not endure the long-term culture. These 
findings possibly reflect altogether the critical role of SMAD inhibition in cell 
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expansion and lumen growth. Dual SMAD-i was sufficient to yield regions with 
strongly enhanced Notch activation alongside radially organized regions in organoids 
(N=9) (Figure 16B). However, areas of high Notch activation did not coincide with 
those of radial organization. In addition, non-neuroepithelial extensions were still 
present. Together with our transcriptional analyses, these results show that the 
posterior fates derived by dual SMAD-i potentially exhibit high Notch activation not 
compatible with capacity for radial organization. 
 
Only when combined, dual SMAD-i and WNT-i treatments led to robust radial 
organization that well overlapped with enhanced Notch activation within organoids 
(N=9) (Figure 16B). This also correlated with significantly increased organoid size 
under this treatment (See Figure 24 for size comparison under different treatments). 
Moreover, non-neuroepithelial extensions were entirely eliminated. High-power 
confocal Z-stacks of organoids across treatments demonstrate the superior effect of 
Triple-i conditions on Notch activation and radial organization (vesicle formation) 
(Figure 17). We interpret the increase in these two features under Triple-i as readout 
for enhancement of NSC identity (stemness) and establishment of robust cell 
polarity, respectively. We also propose that acquisition of these features may be a 
critical step in the process of corticogenesis in vitro. More generally, these results 
demonstrate that early pathway inhibition had a robust effect on shaping the identity, 















Figure 16: Enhanced Notch activation and efficient radial organization are hallmarks of 
transition of PSCs towards neocortical fates and require Triple-i. 
A. Phase contrast (top) and HES5::eGFP (bottom) images of day 12 neural monolayer progenitors 
derived from small EBs (sEBs) subjected to neural induction under inhibitor-free conditions (Inhibitor-
free), WNT inhibition using XAV-939 (WNT-i), dual SMAD inhibition using SB-431542 and Noggin 
(dual SMAD-i) and combined dual SMAD and WNT inhibition (Triple-i). Scale bar: 50 µm. 
B. Merged bright field images and their matched HES5::eGFP confocal images taken from Day 17 
representative organoids (N≥9) derived by indicated treatments. Shown are maximum intensity 
projections for HES5::eGFP confocal images taken at 15µm intervals across each organoid and 
collected to a summed image. Green arrows represent enhanced Notch active and radially organized 
regions (vesicles), white arrows refer to radially organized regions lacking enhanced Notch activation, 
and red arrows refer to non-neuroepithelial extensions. Note the substantial homogeneity in Notch 
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activation, radial organization and lack of non-neuroepithelial extension in Triple-i derived organoids. 
See also organoid size quantification for all treatments in Figure XX. Scale bar: 100 µm 
Figure 17: Enhanced radial patterns in cerebral organoids derived by combined dual SMAD 
and WNT inhibition 
A. HES5::eGFP representative confocal images taken from Day 20 organoids derived under defined 
treatments (N=3 for each day/treatment). Shown is maximum intensity projection of HES5::eGFP 
confocal images taken at 5µm intervals across each organoid (see corresponding z-sections in B). 
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Note the sparse HES5::eGFP expression in vesicles of inhibitor-free organoids. Note organization into 
rosettes but not large vesicles in WNT-i treated organoids (dashed circle). Note irregularity in shape 
and cytoarchitectural organization of HES5::eGFP expressing cells in dual SMAD-i treated organoids. 
Note near complete vesicle organization and enhanced Notch activation in Triple-i treated organoids 
(dashed line). Scale bar: 100 μm. 
B. Confocal z-sections of HES5::eGFP across the Day 20 organoids shown in A. Shown are 
representative images from stacks taken for each treatment, with 33-49 planes collected per stack, 
depending on treatment. Four representative planes per each organoid are shown. Z-stacks appear 
from top to bottom images (representing stacks proximal and distal to objective). Triple-i treatment: 
Basal and apical sites of vesicle ventricular zones are represented by outer and inner dashed lines, 
respectively. Ventricular zone is represented by HES5::eGFP expressing cells located within outer 
and inner dashed lines. Vesicle center (surrounded by inner dashed lines) represents from top to 
bottom to: radial glial cell bodies, radial glial end feet, ventricle of cerebral vesicles. Insets represent 
enlargements of indicated areas in each image (open squares) corresponding from top to bottom to: 
radial glial cell bodies, radial glial end feet, radial glial basal processes, ventricle of cerebral vesicles. 
WNT-i treatment: outer and inner dashed lines represent rosettes that have not developed to vesicles. 
Inset represents enlarged rosette lumen with apparent radial glial end feet. Scale bars for all large 
images: 100 μm. Inset scale bars for Triple-i treatment, from top to bottom: 16.7 μm, 16.7 μm, 33 μm, 
33 μm. Inset scale bar for WNT-i treatment: 33μm. 
 
3.3.2 Radial Organization of NSCs derived under combined dual SMAD and 
WNT inhibition coincides with dorsal cortical markers 
To further support the link between Notch activation, radial organization and the 
acquisition of early cortical identity obtained by Triple-i (Figure 12), we performed a 
series of immunostainings in early 2D and 3D cultures derived under the different 
paradigms. We began with PAX6 and SOX1, two early neuroepithelial markers for 
which double staining is highly ambiguous in determining cortical fates. Here, these 
markers were weakly expressed in inhibitor-free or WNT-i derived monolayer 
cultures (Figure 18), with WNT-i slightly inducing these markers due to its capacity to 
attenuate gastrulation and in agreement with in vivo observations [53, 187]. 
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Figure 18: Poor neural 
induction achieved under 
inhibitor-free and WNT-i 
monolayer conditions 
Combined HES5::eGFP 
reporter expression and 
immunostaining of the early 
neuroepithelial markers PAX6 
and SOX1 (top) along with 
their matched DAPI images 
(bottom) in day 12 neural 
progenitors derived under 
Inhibitor-free (Inhibitor-free) 
and WNT inhibition using 
XAV939 (WNT-i). See Figure 
18 for images taken for other treatments. Scale bar: 50 µm. 
 
On the other hand, both PAX6 and SOX1 markers were highly expressed under dual 
SMAD-i and Triple-i derived progenitors. However, only under Triple-i they were 
homogeneously expressed throughout cultures, co-localized with HES5::eGFP, and 
coincided with efficient radial organization (Figure 19). 
Figure 19: Enhanced Notch activation and efficient radial organization co-localize with 
neuroepithelial markers in monolayers derived by combined inhibition. Immunostaining of PAX6 
and SOX1 with respect to Notch activation (HES5::eGFP) and radial organization in day 12 
monolayer neural progenitors derived by indicated treatments. The right image represents a 
magnified rosette from Triple-i derived progenitors. Scale bar: 50 µm. Note the dramatic shift in 
marker co-localization together with radial organization under Triple-i. Cell counts and co-localization 
analysis of markers are presented at the right panel. Note the increased co-localization of PAX6 with 
HES5::eGFP under Triple-i.  
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When tested in 3D organoids, early neuroepithelial markers SOX2, PAX6 and SOX1 
were comparably expressed under all treatments, again emphasizing ability of 
organoids to self-induce and maintain neural fates regardless of pathway inhibition. 
However only under Triple-i – both expression and co-localization of these markers 
with Notch activation and radial organization was observed (Figure 20A, D). The 
expression of basal progenitor marker TBR2 and early neuronal marker TBR1 is also 
comparable under all treatments (Figure 20A). All these results were also confirmed 
for another human iPSCs (ZIP8K8) derived organoids (Figure 20B). Together with 
the molecular cortical cell identity revealed in Triple-i conditions (Figure 12), our 
observations argue that even when markers such as SOX2, PAX6, SOX1 and HES5 
are expressed in PSC derived neural cells, it is their co-localization with each other 
and their overlap with radial organization which together mark cortical cell fate. 
 
To further correlate the process of radial organization and Notch activation to the 
cortical specification obtained by Triple-i, we looked at the expression of 
telencephalic/cortical marker FOXG1. In monolayer cultures, this telencephalic 
marker was upregulated in both dual SMAD-i and Triple-i conditions (Figure 20D), in 
line with our own observations [119, 127, 146], with observations from the same 
group [121, 125, 126] as well as others [188]. But only under Tripe-i, this marker was 
expressed in nearly all neuroepithelial cells, where it also coincided with radial 
organization and Notch activation (Figure 20C). Organoids derived by Triple-i also 
exhibited expression of FOXG1 in radially organized regions (vesicle areas) together 
with Notch activation (Figure 20D), demarcating them as telencephalic/cortical in 
nature. However, FOXG1 was only partially expressed under inhibitor-free conditions 
and was completely absent under dual SMAD-i conditions. The lack of FOXG1 in 
organoids under dual SMAD-i indicated that in the absence of WNT inhibition, self-
organizing structures are inherently predisposed towards non-telencephalic fates, 
while 2D systems exhibit both telencephalic and non-telencephalic cell types. 
 
Finally, we linked Notch activation and radial organization to cortical specification by 
looking at the expression pattern of PAX6 and EMX2. Within the cortex, PAX6 and 
EMX2 are expressed rostrally and caudally but share large co-expression regions 
dorsally [189]. Yet, these markers cannot be simply interpreted as cortical markers 
as they are also expressed in thalamic regions of the diencephalon as well as in the 
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hippocampus [190]. Indeed, we found that in both monolayers and organoids 
expression of PAX6 and EMX2 was induced under both dual SMAD-i and Triple-i 
(Figure 20C, D). These results were also confirmed for another human iPSCs 
(ZIP8K8) derived organoids (Figure 20E). However, because most progenitors 
derived by Triple-i express FOXG1, then such FOXG1+/PAX6+/EMX2+ (Figure 21A) 
expressing cells seen under Triple-i must represent dorsal cortex progenitors. 
Compatible with this interpretation, also PAX6 and EMX2 expressing cells were co-
localized with radially organized Notch active cells under Triple-i conditions only, 
providing evidence that enhanced Notch activation coinciding with radial organization 
are exclusive hallmarks of PSC transition towards cortical fates, rather than towards 
general CNS or forebrain fates – in a process that requires combined dual SMAD 






























Figure 20: Enhanced Notch activation and efficient radial organization co-localize with cortical 
markers in monolayers and organoids derived by combined inhibition. 
A. Immunostaining images of SOX2/TBR2 (top) and SOX2/TBR1 (middle), with respect to Notch 
activation (HES5::eGFP) and radial organization in day 30 organoids derived from HES5::eGFP 
hESCs under indicated treatments. Note dramatic Notch activation and neural stem cell marker 
(SOX2) co-localization together with radial organization under Triple-i. Intermediate progenitor marker 
(TBR2) and deep cortical layer neuronal marker (TBR1) emerges at basal sites of radially organized 
vesicles in all treatments. Cell counts and co-localization analysis of HES5::eGFP expression and 
indicated markers are presented at the bottom. Scale bar: 100 µm. 
B. Immunostaining images of SOX1/TBR2 (top) and SOX1/TBR1 (middle), with respect to radial 
organization in day 30 organoids derived from ZIP8K8 iPSCs under indicated treatments. Cell counts 
of indicated markers are presented at the bottom. Scale bar: 100 µm. 
C. Immunostaining images of FOXG1 (top) and PAX6/EMX2 (middle) with respect to Notch activation 
(HES5::eGFP) and radial organization in day 12 monolayer neural progenitors derived by indicated 
treatments. The right image represents a magnified rosette from Triple-i derived progenitors. Note the 
dramatic shift in marker co-localization with Notch coincided with radial organization under Triple-i. 
Cell counts and co-localization analysis of markers are presented at the right panel. Note the 
increased co-localization of PAX6 and FOXG1 with HES5::eGFP under Triple-i. Scale bar: 50 µm. 
D. Immunostaining images of SOX1/FOXG1 (top) and PAX6/EMX2 (middle) with respect to Notch 
activation (HES5::eGFP) and radial organization in day 30 organoids derived from HES5::eGFP 
hESCs under indicated treatments. Cell counts and co-localization analysis of HES5::eGFP 
expression and indicated markers are presented at the bottom panel. Note the enhanced marker co-
localization with Notch activation coincided with radial organization under Triple-i. Scale bar: 100 µm. 
E. Immunostaining images of SOX1/FOXG1 (top) and PAX6/EMX2 (middle), with respect to radial 
organization in day 30 organoids derived from ZIP8K8 iPSCs under indicated treatments. Cell counts 
of indicated markers are presented in the Figure 21. Scale bar: 100 µm. 
 
We then dissected the cortical areal homogeneity (Figure 21A) of Triple-i derived 2D 
monolayer progenitors and whole 3D organoids by immunostainings of concerned 
marker gene expression. While EMX2 is expressed in the cortex dorsally-medially 
with slight bias caudally, SP8 is an additional marker expressed in the cortex dorso-
medially with a bias rostrally. We therefore further characterized cortical progenitors 
derived by Triple-i by assessing the expression and co-localization of these markers 
with respect to PAX6 (Figure 21B, C). To better quantify expression proportions, 
here we performed acute rosette dissociation, fixing and staining, hence the lack of 
rosette structures. Cells derived by Triple-i abundantly expressed EMX2 (59%) or 
SP8 (86%), out of which percentages 78% and 69% co-expressed PAX6, 
respectively (Figure 21B), supporting for dorsal cortical identity. This remarkable 
84 
 
abundance and co-localization of dorsal-medial-caudal (EMX2) and dorsal-medial-
rostral (SP8) markers with PAX6 under Triple-i suggested that this treatment mainly 
induced a pan dorsal-medial cortical identity. This is further supported by the 
expression of OTX2 and COUP-TF1. In the telencephalon, these markers are 
expressed only ventrally and laterally, respectively, but not dorsally. Indeed, both 
markers were poorly expressed in Triple-i derived progenitors (Figure 21B), 
supporting the presence of dorsal identity. Keeping with these observations in 2D 
cultures, we confirmed the expression pattern of EMX2, PAX6, SP8 and COUP-TF1 


















Figure 21: Enriched dorsal cortical fate derivation under combined inhibition. 
A. Mouse In-situ hybridization images of Foxg1, Pax6, Sp8, Emx2, Coup-Tf1 and Otx2 obtained from 
Allen Brain Atlas and illustration depicting regions induced by mentioned treatments. Cortical 
progenitors entail unique co-expression of all indicated markers (except Otx2 and Coup-Tf1) in 
discrete as well as shared regions confined within the dorsal telencephalic domain. NCX- Neocortex, 
MP-Medial pallium, SP-Sub pallium, DIEN-Diencephalon, MB-Midbrain and HB-Hindbrain. 
B. Immunostainings of EMX2, SP8 and COUP-TF1 with respect to PAX6, as well as of OTX2, in day 
12 dissociated rosette progenitors derived from ZIP8K8 iPSCs by indicated treatments. Cell counts 
and co-localization analysis are presented at the bottom panel. Scale bar: 50 µm. Note increased co-
localization of EMX2 and SP8 with PAX6, as well as reduced OTX2 expression, under Triple-i. 
C. Immunostainings of EMX2, SP8 and COUP-TF1 with respect to PAX6, as well as of FOXG1, in day 
27 organoids derived from ZIP8K8 iPSCs by indicated treatments. Cell counts and co-localization 
analysis are presented in the right panel. Note the exclusive expression of FOXG1, as well as 






As the current known cortical markers expression is not unambiguous for identifying 
cortical cell types, we next looked for the expression of novel genes that were 
enriched in cortical regions and also in non-cortical regions (medial pallium, 
diencephalon and cerebellum) of Allen human brain regional transcriptional dataset 
and our organoid transcriptional dataset derived under different treatments (Figure 
14) and validated by immunostainings (Figure 22). We confirmed the expression of a 
novel cortical neuronal marker TIAM2 basally to SOX2 positive vesicles only in the 
Triple-i generated organoids. MEF2C was another novel cortical marker enriched in 
Triple-i organoids that was expressed in both VZ progenitors co-localizing with SOX2 
and neurons co-localizing with DCX basally to the vesicles. We next also confirmed 
the expression of non-cortical thalamic markers such as OLIG3 and TCF7L2 and 
medial pallium/choroid plexus markers such as LMX1A and TTR specific to the 
organoids generated by Inhibitor-free and dual SMAD-i (Figure 22).  
Finally, we confirmed the lack of ventral specification in the absence of WNT by 
testing the expression of the ventral markers NKX2.1 and NKX2.2 in organoids. We 
found that these markers were observed in inhibitor-free and dual SMAD-i derived 
organoids, but not in Triple-i derived organoids (Figure 23A). In accordance, the 
inhibitory neuronal marker GAD65 was attenuated in Triple-i derived organoids 
(Figure 23B). Together these results show that combined inhibition is indispensable 



















Figure 22: Expression of novel cortical and non-cortical genes in organoids derived under 
diverse inhibition paradigms 
Immunostainings of cortical markers TIAM2, MEF2C with respect to neural stem cell marker SOX2 
and neuronal marker DCX and non-cortical markers OLIG3/TCF7L2 (diencephalic markers), 
TTR/LMX1A (medial pallium markers) in day 27 ZIP8K8 iPSCs organoids derived under indicated 
treatments. Cell counts analyses are presented at the right panel. Scale bar: 100 µm. Note 
enrichment of cortical markers in Triple-i generated organoids and non-cortical markers in dual 






Figure 23: Decreased ventral patterning in Triple-i derived organoids.  
A. Combined HES5::eGFP reporter expression and immunostaining for the ventral markers NKX2.1 
and NKX2.2 in day 30 organoids derived under indicated treatments. Note lack of expression under 
Triple-i. Scale bar: 100 µm.  
B. Combined HES5::eGFP reporter expression and immunostaining of the GABAergic neuronal 
marker GAD65 in day 30 organoids derived under indicated treatments. Expression of GAD65 is 
attenuated in Triple-i organoids. Scale bar: 100 µm. 
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3.4 Combined dual SMAD and WNT inhibition allows standardized modeling of 
microcephaly  
Our study demonstrates that current derivation methods for cortical fates yield in fact 
heterogeneous cell populations with distinct identities both molecularly and cellularly, 
and further argues that only combined dual SMAD and WNT inhibition reproduces 
neocortical fares. This conclusions postulate that iPSC-based cortical disease 
modeling systems relying on diverse methods will essentially provide distinct 
phenotypes. To provide a proof of concept to this idea, we generated a homozygous 
microcephaly mutation in the same isogenic HES5::eGFP human ESC line by 
Crispr/Cas9 technology. This mutation was generated by a Guanine deletion in 1218 
amino acid position of the centriolar gene STIL, resulting in a truncated protein 
(Figure 24) known to eventually cause autosomal recessive microcephaly in humans 
[152]. 
 
Figure 24: General description on microcephaly mutant cell line. 
Description of the STIL protein including the STAN and KEN domains, as well as microcephaly 
mutations (top). Normal (WT) and planned mutated (STIL) nucleotide sequence adjacent to the region 
corresponding to the 1218a.a (bottom left). Genome edited sequencing results (bottom right). A-
alanine, F-phenylalanine, L-leucine, V-valine and *- stop codon. 
 
We first assessed general microcephaly features in our STIL mutated organoids with 
respect to treatments. Microcephaly organoid size was significantly smaller than that 
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of WT organoids only when derived by Triple-i (Figure 25), suggesting profound 
reduction in cortical size compared to non-significant reduction in other brain regions.  
 
Figure 25: Microcephaly organoids derived under combined inhibition show significant size 
reduction compared to their wildtype counterparts. 
Merged bright field images and their matched HES5::eGFP confocal images obtained from day 17 
representative organoids derived from wildtype (WT) or microcephaly (MC) mutant hESCs under 
indicated treatments. Shown is maximum intensity projection of HES5::eGFP confocal images 
obtained at 6µm intervals across each organoid. Scale bar: 100 µm. Right: Boxplots representing 
organoid size obtained from multiple organoids determined by measuring areas of collapsed 
maximum intensity projection images obtained from day 17 WT and MC mutant organoids derived by 
different treatments (N>12 for each treatment). MC mutant organoids are significantly smaller than 
their WT counterparts only if derived by Triple-i. Statistics: Boxplots represent median and 
interquartile ranges. Statistical test: t-test; *P < 0.05; **P < 0.01 ***P < 0.001; ****P < 0.0001. 
 
In addition, we observed an increase in differentiation compared to proliferation in 
day 20 organoids based on DCX and SOX2 area thickness ratios (Figure 26A), but 
this feature was not unique to cortical tissues as it appeared in other derivation 
methods as well. We also assessed vesicle growth by measuring the net 
neuroepithelial (vesicle) areas as well as outer and inner lumen perimeters and 
found significant reduction in both measures in microcephaly organoids (Figure 26B). 
However, also this reduction was not cortex specific as it occurred in both dual 
SMAD-i and Triple-i derived organoids. These results suggested that compromised 
size was caused by loss in progenitor pools, yet not necessarily due to cortex 
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specific cell loss. We further found that the number of P-VIM+ dividing radial glial 
cells captured along ventricular linings of microcephaly vesicles was higher 
compared to those observed for WT vesicles (Figure 26C). This suggested a 
possible mitotic arrest that could naturally occur in any brain region due to impaired 
centrosome biogenesis (for Review See [191]. Indeed, on day 30 it was already 
obvious that ventricular linings were ruptured and contained clustered centrosomes 
and poor co-localized cilia at basal bodies (Figure 26D). In addition, centrosomes 
appeared larger in size, reflective of potential centrosome clustering due to excess 
centrosome duplication, in line with previous studies [165, 192]. Collectively, these 
results suggested an overall impairment in developmental programs related to all 
























































Figure 26: Differential phenotypic modeling of microcephaly in organoids derived by diverse 
pathway inhibition paradigms. 
A. Combined HES5::eGFP expression and immunostaining images for the neural progenitor marker 
SOX2 and the early neuronal marker DCX in day 20 WT and MC mutant organoids derived under 
Triple-i conditions. Four-fold magnifications of regions in left images are shown on the right. 
Quantification of SOX2 and DCX area proportions within vesicles obtained WT or MC organoids 
derived by indicated treatments. Scale bar: 100 µm. Statistics: Stacked columns represent relative 
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SOX2 (red) and DCX (blue) expression within selected areas from WT and mutant vesicles. Statistical 
test: t-test; *P < 0.05; **P < 0.01 ***P < 0.001; ****P < 0.0001. 
B. Measurement of ventricular zone areas in WT and mutant organoids. Dashed lines in A mark 
representative ventricular zone-like areas and luminal areas within vesicles of day 20 WT and MC 
mutant organoids derived under Triple-i conditions. Boxplots represent measurements for ventricular 
and luminal areas of organoids derived by indicated treatments. Shown are data representative of at 
least 10 vesicles extracted from at least 5 representatives WT or MC organoids. Statistics: Boxplots 
represent median and interquartile range. Statistical test: t-test; *P < 0.05; **P < 0.01 ***P < 0.001; 
****P < 0.0001. 
C. Combined HES5::eGFP expression and immunostaining images for the dividing radial glial marker 
P-VIM along with their corresponding DAPI images for day 20 WT and MC mutant organoids derived 
under Triple-i conditions. Right: cell counts of luminal P-VIM in WT and MC organoids derived by 
indicated treatments. 
D. Immunostaining of the centrosomal marker PERICENTRIN (PCNT) and the ciliary protein marker 
γ-TUBULIN in day 30 WT and MC organoids derived under Triple-i conditions. Ten-fold 
magnifications of regions within the left images are shown on the right. Note the ruptured morphology 
of apical lining as judged by non-continuous centrosome appearance. Note centrosome clustering 
and attenuated ciliary staining in mutant MC organoids. 
 
3.4.1 Significant reduction in cortical gene expression and massive apoptosis 
in microcephaly organoids occurs only under combined inhibition  
To gain a better insight into disease etiology, we performed RNA-Seq for day 17 and 
day 30 organoids carrying the homozygous 1218 STIL mutation and which were 
derived by the different protocols. We first integrated the resulting RNA-Seq 
analyses together with their WT counterparts into the same CA plot generated for 
Figure 12. We found that microcephaly organoids clustered with their WT 
counterparts, according to their derivation method. Notably however, day 30 Triple-i 
derived microcephaly organoids appeared most distally in the entire Triple-i derived 
organoid cluster, where they were interfacing with day 30 dual SMAD-i derived 
organoids (Figure 12). Since microcephaly organoids derived by Triple-i were 
smaller but did not become extinct in culture, these results imply that cortical 
structures derived under Triple-i were greatly diminished, yet some residual non-
cortical fates that could still form under Triple-i remained intact. 
 
Since these results implied that cortical fates were more susceptible than other fates 
in microcephaly, we looked at genes associated with regional specification 
throughout WT and microcephaly organoid development. We extracted from day 17 
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and 30 organoids expression values of gene categorized to groups with distinct 
regional signatures (neocortex, medial pallium, diencephalon, mid-hindbrain) and 
compared them across derivation methods and disease state (WT, microcephaly) 
(Figure 27A). We found that changes in gene expression distributions for the 
different regional signatures in day 17 organoids were not significant across 
treatments (Figure 27A), but became so after 30 days in culture, compatible with our 
global transcriptional analysis for day 30 organoids (Figure 12). The most dramatic 
differences on day 30 organoids were observed for cortical genes which were 
significantly reduced in microcephaly organoids generated only under Triple-i. This 
result strongly confirms the loss of cortical structures in microcephaly organoids 
generated under Triple-i. However, interestingly expression of posterior fate 
(diencephalon and mid/hindbrain) genes were upregulated in both Triple-i and 
inhibitor-free generated microcephaly organoids. This result indicates a major loss of 
cortical cells accompanying with the promotion of tissues posterior to cortex. 
Whereas microcephaly generated under dual SMAD-i treatment didn’t show any 
significant changes from its wild type counterparts (Figure 27A). Collectively, these 
results show that microcephaly development culminates in major reduction of cortical 
fates and a modest elevation of posterior fates under Triple-i conditions. 
 
To further support the differences observed in the gene expression of microcephaly 
organoids, we next employed a global gene set enrichment analysis of gene 
expression data sets generated from both wild type and microcephaly organoids 
across all treatments using ingenuity analyses. In support to the major loss of cortical 
gene expression in microcephaly organoids, we observed the downregulation of 
represented tissues like forebrain, telencephalon, and cerebral cortex in 
microcephaly organoids generated under all treatments, but much more pronounced 
in Triple-i generated organoids (Figure 27B). In accordance, we observed the 
downregulation of pathways related to cell cycle and notch signalling in d30 
microcephaly organoids which could be the reason for cortical structures loss (Figure 
27C). In addition, we have also observed an increase in neurogenesis in early day 
17 microcephaly organoids (Figure 27C) which in turn is reflected in the SOX2/DCX 
immunostainings of microcephaly organoids (Figure 26A). These results suggest that 
the compromised size in microcephaly was caused by both the loss of progenitor 
pool (notch downregulation) accompanied with accelerated differentiation. In line 
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with the elevation of non-cortical fates in microcephaly organoids (Figure 27A), 
ingenuity analysis showed the upregulation of tissues such as formation of 
mesencephalon, eye and sensory system development along with upregulation of 
canonical pathways like PCP and Wnt/beta-catenin signalling under inhibition-free 
and Triple-i microcephaly organoids (Figure 27C). Interestingly, only dual SMAD-i 
microcephaly organoids showed matured neuronal phenotypes like upregulation of 
neuritogenesis, axonogenesis and canonical pathways such as CREB, glutamate 
and GABA receptor signalling. This could be resulting from the intact non-cortical 








Figure 27: Differential molecular phenotypes of microcephaly organoids derived by diverse 
pathway inhibition paradigms. 
A. Differential gene expression and gene set enrichment analysis (bar plot) of brain regions 
(neocortex, medial pallium, diencephalon and mid/hindbrain) for day 17 (top) and day 30 (bottom) WT 
vs MC organoids derived under indicated treatments. Note significant reduction in cortical gene 
expression in day 30 organoids derived under Triple-i condition only. 
B. Tissues overrepresented in ingenuity gene enrichment analysis of differentially expressed genes 
for day 17 and day 30 WT vs MC organoids derived under indicated treatments. 
C. Pathways overrepresented in ingenuity gene enrichment analysis of differentially expressed genes 
for day 17 and day 30 WT vs MC organoids derived under indicated treatments. 
  
We have also observed an upregulation of apoptosis pathway in microcephaly 
organoids generated under Triple-i in gene enrichment analysis (Figure 27B) and 
therefore tested for apoptosis by immunostaining. We strikingly found that activated 
Caspase-3 was substantially expressed in Triple-i derived microcephaly organoids, 
but absent in inhibitor-free microcephaly organoids and only sparsely present in dual 
SMAD-i derived microcephaly organoids, demonstrating cortex-specific cell death 
(Figure 28). Remarkably, cell death under Triple-i was restricted to Notch active and 
radially organized regions. This finding suggested that execution of programmed cell 
death possibly initiated in apical radial glial neural stem cells (hence Notch active 
and radially organized cells) residing within the cortical ventricular zone. This further 
supported the fact that despite the fact that genetic centrosomal defects existed in all 
organoid cells, cortical progenitors were exclusively affected. Thus, together with our 
data on cortical specification under Triple-i, we conclude that combined inhibition is 





Figure 28: Microcephaly organoids show cortex specific death only when derived under 
combined inhibition. 
Combined HES5::eGFP expression and immunostaining images of the apoptotic marker CAS-3 in 
day 20 WT and MC mutant organoids derived by indicated treatments. Three-fold magnification 
images for Triple-i derived organoids are shown on the right. Note the dramatic increase in CAS-3 
expression adjacent to HES5::eGFP vesicles under Triple-i. Scale bar: 100 µm. 
 
3.5 Single cell RNA Sequencing of organoids reveals enrichment for cortical 
fates in organoids derived by combined dual SMAD and WNT inhibition  
We next did scRNA sequencing on mature organoids such as day 50 organoids to 
know about long term regional and differentiation capabilities of organoids generated 
under all treatments. The average number of genes detected per cell (1040 in 
Inhibitor-free, 1199 in dual SMAD-i, 1204 in Triple-i, and 1072 in WNT inhibition) 
were comparable in all treatments. To compare how different day 50 organoids from 
day 30 organoids in terms of brain regional specifications, we compared relative 
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expression levels of regional genes across organoids derived by these four different 
protocols in bulk RNA-Seq of day 30  organoids with scRNA-Seq of day 50 
organoids (Figure 29A). We observed preservation of enriched cortical fates in 
organoids generated under Triple-i with no posterior fate contamination whereas in 
dual SMAD-i generated day 50 organoids preserved posterior fates along with a 
medium enrichment of cortical fates. Inhibitor-free organoids show poor and sporadic 
expression of both cortical and non-cortical gene expression. 
 
We then employed a global gene set enrichment analysis on day 50 organoids 
simulated bulk RNA-Seq data generated by each treatment (Figure 29B). Overall top 
over represented tissues in each comparison reveal enriched cortical fates like 
telencephalon, neocortex in Triple-i, non-cortical fates like thalamic structures, 
midbrain structures and hindbrain in dual SMAD-i. While inhibitor-free is enriched for 
mesenchyma, ECM and neural retina fates. 
 
We next looked in to differently expressed genes in stem cell domain 
(SOX2+HES5+) and neuronal domain (DCX+) cells generated under Triple-i and 
dual SMAD-i treatments (Figure 29C). We observed that the top 1000 genes that are 
upregulated under Triple-i condition in both stem cell and neuronal cells are cortical 
genes like FOXG1, LHX2, SFRP1, NFIA and NFIB whereas dual SMAD-i generated 
stem cell and neuronal cells are enriched for non-cortical genes like ZIC1, ZIC2, 




















































































Figure 29: Single cell RNA-Seq reveal cortical cell fate maintenance in mature organoids 
derived under combined inhibition. 
A. A heatmap representing expression values for selected genes categorized according to neural 
stem cell markers and regional markers (neocortex, medial pallium, diencephalon and midbrain-
hindbrain) in day 30 Bulk RNA-Seq and day 50 simulated scRNA-Seq data derived under indicated 
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treatments. Color-coded scale represents relative expression levels of each gene (row) across 
treatments. Note the expression of cortical cell markers are maintained without the contamination of 
non-cortical cell fates in day 50 organoids derived under Triple-i. 
B. Genomatix gene enrichment analysis for all pairwise comparison of day 50 organoid RNA-Seq 
expression data derived under indicated treatments. Color-coded scale represents relative –log p 
value levels in each comparison (column). Note telencephalic/cortical gene ontology terms enriched in 
Triple-i derived organoids. 
C. A heatmap of  log2 fold changes estimated from scRNA-Seq expression levels in neural stem cell 
(HES5+SOX2+) and neuronal (DCX+) population of day 50 Triple-i derived organoids compared to 
dual SMAD-i derived organoids. Color-coded scale represents gene expression levels (column). Note 
cortical genes are enriched in both stem cell and neuronal population of Triple-i derived day 50 
organoids with important genes highlighted.  
 
We then clustered cells from inhibitor-free, dual SMAD-i, and Triple-i day 50 
organoids together in order to distinguish between similar and distinct cell 
populations across these three protocols (see methods for details), and identified 12 
clusters in total (Figure 30A).  The t-SNE map shows that most of the cells generated 
under dual SMAD-i and Triple-i were clustered together, whereas inhibitor-free 
generated cells were clustered separately (Figure 30B).  FOXG1 expression level 
was used to distinguish cortical from non-cortical clusters (Figure 30C).  A total of 
91% of cells in Triple-i organoids and 68% of cells in dual SMAD-i organoids were 
assigned to cortical clusters.  Only 5% of cells in inhibitor-free organoids were 
assigned to cortical clusters (Figure 30D). We have observed a high percentage of 
cortical stem cell population (SOX2+HES5+PAX6+FOXG1+) in Triple-i (73%) 
compared to dual SMAD-i (46%) and inhibitor-free (10%) conditions (Figure 30E). 














Figure 30: Enriched cortical population (stem cell and their progeny) in organoids derived 
under combined inhibition. 
A. Combined t-distributed stochastic neighbor embedding (tSNE) plots for single cell RNA sequencing 
data of Day 50 organoids derived under indicated treatments reveals 12 (C1-C12) distinct clusters 
highlighted in different colors. 
B. Combined t-distributed stochastic neighbor embedding (tSNE) plots for single cell RNA sequencing 
data of Day 50 organoids derived under indicated treatments highlighted in different colors. Color 
code: yellow-Triple-i, purple-dual SMAD-i and green-inhibitor-free. 
C. tSNE plot with telencephalic/cortical marker FOXG1 expression level plotted as a gradient (gray 
values signify no reads mapping to FOXG1 detected in the respective cell). 
D. Bar plot representing percentage of cortical population based on FOXG1 expression in day 50 
organoids derived by indicated treatments. 
E. Bar plot representing percentage of cortical stem population based on FOXG1, SOX2, HES5 and 
PAX6 expression in day 50 organoids derived by indicated treatments. 
 
We characterized each cluster based on the expression of marker genes (Figure 
31A). We observed five out of twelve clusters (C2, C8, C6, C4 and C1) with high 
FOXG1 expression levels, and denote these clusters as cortical clusters.  From the 
heatmap (Figure 31B), we validate these clusters as cortical by highlighting the lack 
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of diencephalic and midbrain/hindbrain genes in these clusters accompanied with 
high levels of FOXG1 expression. Out of these FOXG1+ cortical clusters, C2 and C8 
express neural stem/progenitor markers such as SOX2, SOX1 and HES5. C4 
expresses intermediate progenitor marker EOMES, and C1 expresses neuronal 
markers NEUROD6, TBR1 and DCX. C6 expresses a mixture of both stem cell and 
neuronal marker genes, signifying that these cells are in a transitory state between 
stem cell and intermediate progenitor/neuron (Figure 31A).  This suggests that the 
cortical populations observed in these organoids recapitulate the expression patterns 
observed during in vivo corticogenesis.  Out of the seven non-cortical clusters, C10 
expresses high levels of the stem cell/progenitor markers SOX2, SOX1 and HES5, 
as well as posterior markers of medial pallium, diencephalon and mid/hindbrain 
regions. C5 expresses high levels of the neuronal marker DCX, along with 
diencephalic and mid/hindbrain regional markers, indicating non-cortical stem cell 
and neuronal clusters respectively (Figure 31A, B). These clusters were mostly 
comprised of cells from dual SMAD-i organoids (55% in C10 and 70% in C5), a 
further indication that dual SMAD-i enriches for diencephalic and mid/hindbrain 
regions.  C9, C3 and C7 express neural retina progenitor markers VSX2, PAX6 and 
RAX, and C12 expresses retinal pigmental epithelial (RPE) progenitor markers 
PAX6, OTX2 and RAX [193]. These clusters are mainly comprised of cells generated 
by inhibitor-free organoids (Figure 31A, B). These findings not only support our 
results from day 30 organoid bulk RNA-Seq comparisons that Triple-i organoids 
enrich for cortical marker genes and dual-SMAD-i organoids enrich for thalamic and 
midbrain/hindbrain genes, but highlight an important finding, that dual-SMAD-i 
organoids also produce cortical populations which are indistinguishable from the 

















Figure 31: Combined inhibition organoids show homogeneous and increased cortical cellular 
composition mimicking in vivo corticogenesis. 
A. Bar plot representing expression (RP10K) values for selected (brain regional specific and cortex 
cell type specific) genes in day 50 organoids derived by indicated treatments. The relative height of 
the stacked bars represents the proportion of reads within each cluster detected in cells across the 
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indicated treatments. General cortical marker: FOXG1, non-cortical markers: OTX2, GBX2 and VSX2, 
shared cortical and non-cortical markers: PAX6, EMX2 and SP8, neural stem cell markers: SOX2, 
SOX1 and HES5, intermediate progenitor marker: EOMES and neuronal markers: NEUROD6, TBR1 
and DCX. Color code: yellow-Triple-i, purple-dual SMAD-i and green-inhibitor-free.  
B. A heatmap representing expression values for genes marking neural stem cells as well as different 
brain regions (Neocortex, Medial pallium, Diencephalon and Mid/Hindbrain), with pie charts above 
displaying percentages of cells from each indicated treatments and bar plots displaying the total 
number of cells within each cluster. Color-coded scale represents relative expression levels of each 
gene (row) across clusters. Color code: yellow-Triple-i, purple-dual SMAD-i and green-inhibitor-free. 
Note the increased cortical cell populations in Triple-i derived organoids. 
 
3.6 Cortical layer markers appear more homogeneously under combined dual 
SMAD and WNT inhibition  
Ultimately, we also assessed cortical lamination capability in Triple-i and dual SMAD-
i derived organoids using immunostaining for deep and upper cortical layer markers 
in day 80 and day 120 organoids. We observed the expression of both deep (TBR1, 
CTIP2 and to lower extent SATB2) and upper (CUX1, CUX2 and SATB2) layer 
markers in organoids derived by both treatments in day 80 and day 120 organoids 
(Figure 32A). Despite these similarities in marker expression between Triple-i and 
dual SMAD-i, we did observe differences in the cytoarchitectural organization of the 
corresponding neurons within organoids vicinity. We found that cortical layer neurons 
populated organoid peripheries much more homogeneously in Triple-i organoids 
compared to dual SMAD-i organoids, suggesting appropriate cortical layer formation. 
This was observed qualitatively (Figure 32A), but also validated quantitatively as 
judged by the more variable apical to basal distribution of deep or upper cortical 
layer markers in dual SMAD-i derived organoids (Figure 32B). This suggested that 
only when the correct cortical neuronal types are specified – possibly via Triple-i 
conditions – these perform efficient migration distally, to properly populate their 
destined layers. Finally, we also found that although superficial neuronal markers did 
not yet migrate beyond deep layer neuronal markers in day 80 organoids, they did 
eventually begin to show some of that migration in day 120 organoids. However 
again, this phenomenon was obtained regardless of the derivation method. 
Together, these results propose that the efficient cortical differentiation and 
lamination, depends on correct cortical fate acquisition at the starting populations 























































































Figure 32: Efficient cortical lamination was observed in organoids derived under combined 
inhibition. 
A. Immunostaining images for TBR1/CUX1, CTIP2/CUX2 and CTIP2/SATB2, for day 80 (left) and day 
120 (right) organoids derived by indicated treatments. Note the comparable appearance of cortical 
lamination markers irrespective of the derivation method in both day 80 and day 120 organoids. For 
day 120 organoids, enlarged regions are shown on the right. Note the beginning cortical layer 
separation between deep and upper cortical neuronal layers in day 120 organoids. (Landscape 
orientation) 
B. Quantification of apical to basal cortical lamination marker distribution in organoids derived by 
indicated treatments. Schematic showing whole organoid with apical to basal site, distributed in to 
four equal sequential radial portions. Charts represent variances calculated for the number of relative 
marker-expressing cells across selected sub-regions within each of four equally defined sequential 
radial segments comprising each organoid, from the most basal radial segment (denoted as the most 
outer segment; 75-100%) to the most apical radial segment (denoted as the most inner segment; 0-
25%). Note the highest variances obtained for distribution of all cortical layer markers at basal sites 
(75-100%) in dual SMAD-i compared to Triple-i derived organoids, suggesting efficient migration and 























The ability of PSCs to differentiate into lineage specific cell types, for example neural 
lineage, has led to the development of differentiation protocols for the derivation of 
distinct neuronal and glial subtypes. However it is still difficult to generate clinically 
relevant cell types such as specific type of cortical neurons at high purity for 
regenerative medicine due to the enormous heterogeneity that is generated during 
culture. One of the major obstacles in addressing heterogeneity is revealing how 
diversity is generated within starting populations - the earliest progenitor populations 
of a given lineage. Starting populations are considered to hold limited heterogeneity 
with respect to cell identity composition. It is therefore speculated that access to 
such populations should gain insights into their basic biology and ultimately allow the 
development of methods to increase their purity and potentially reveal mechanisms 
governing their self-renewal. In that respect, PSCs still hold the best example for a 
successfully “captured in time” and considerably homogeneous starting population 
[70, 194] - a phenomenon that eventually allowed establishment and maintenance 
of, as well as reprogramming towards distinct pluripotent stem cell states [169, 195-
200]. 
 
In this study we show that early neocortical neuroepithelial cells—the starting 
population of neurons and glia of the developing neocortex—can be derived from 
human PSCs with remarkable regional homogeneity that is also correlated with 
enhanced radial organization and stem cell state (Notch activation). Numerous 
protocols to derive neural fates - and particularly early cortical fates - have been 
proposed, many of which are evenly conceived by the community. However, our 
study shows that when compared side by side, these methods lead to completely 
different cellular identities, arguing for distinct cell commitment already at the early 
neural patterning phase. In 2D monolayer cultures, dual SMAD inhibition produces 
mixed fates consisting of cortical and non-cortical identities, while combined 
inhibition induces only dorsal cortical identity. Moreover, we observed that 
anterior/cortical genes are upregulated on day 8 under both dual SMAD-i and Triple-i 
conditions. However, only in Triple-i, cortical gene expression is maintained and 
enriched in subsequent days i.e., day 10 and day 12, while their expression is 
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declined with concomitant upregulation of posterior/non-cortical genes in dual 
SMAD-i conditions. This was reminiscent of early studies in frogs where anterior 
neural axis fates developed first, from which only later transformed to posterior fates 
(Nieuwkoop’s theory) in the absence of WNT inhibitory signal from AVE. Early 
progenitors derived by dual SMAD-i treatment upregulates diencephalic and 
midbrain-hindbrain genes already on day 8 and these markers consistently 
increased up to day 12, demonstrating the early starting populations were 
heterogeneous with posterior bias. These data in turn suggest that while capacity to 
develop anterior/cortical bias occurs by default but actual commitment to cortical 
fates require exogenous WNT inhibition on top of dual SMAD inhibition. In early day 
30 organoids, inhibitor-free conditions produce mixed regional fates with moderate 
efficiency, while dual SMAD inhibition promotes predominantly posterior fates. 
However, only combined inhibition induces a robust and stable dorsal telencephalic / 
cortical fate. Thus, our findings propose that many of the obstacles inherent to 
heterogeneity during differentiation from PSCs can be resolved by correct 
specification of early starting populations. Also, in analogy to PSCs, such highly 
specified early cortical progenitors should serve as a convenient platform for 
addressing self-renewal capabilities and cell fate conversion in culture.  
 
We show here that the generation of such homogeneous cortical starting populations 
is attributed to addition of WNT inhibition on top of dual SMAD inhibition. While dual 
SMAD inhibition directs efficient neural conversion, WNT inhibition restricts 
gastrulation together with specifying the cortical domain. As shown for both 
monolayers (rosettes) and organoids, only combined inhibition results in the 
compelling specification towards dorsal cortical fates, demonstrating that WNT 
inhibition on top of dual SMAD inhibition is imperative for rectifying the heterogeneity 
generated during neural conversion.  
 
Attributing derivation of cortical fate identity to combined dual SMAD and WNT 
inhibition, and the induction of diencephalic and mid-hindbrain fates to dual SMAD 
inhibition in day 30 organoids, was enabled mainly by our corresponding analyses, 
which compared 10,000 differentially expressed genes among multiple organoids 
derived by the different treatments and cortical and non-cortical human embryonic 
CNS samples. This powerful framework showed that this difference between 
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methods and their outcomes is unequivocal. Gene set enrichment analysis of 
differentially expressed gene candidates reveal significant enrichment of cortical 
fates in combined inhibition vs diencephalic and mid-hindbrain fates in dual SMAD-i 
treatment. Comparing them with Allen human brain regional markers disclose 23 
candidate genes enriched in combined inhibition are also highly expressed in vivo 
human cortical tissue. In addition, heatmap comprising 52 genes reflective of distinct 
regional markers further corroborates the dichotomy between methods and fates and 
also reveals the heterogeneity between individual organoids derived under same 
condition. Co-localization of dorsal cortex markers together with neural stem cell 
markers at the immunostaining and single-cell RNA-Seq levels further confirms 
homogeneity of cortical cellular identity achieved by combined inhibition. Single cell 
RNA-Seq shows the homogenous derivation of cortical populations (93%) under 
combined inhibition vs dual SMAD-i (63%) and inhibitor-free (5%). Dual SMAD-i and 
inhibitor-free conditions also promotes the generation of non-cortical tissues such as 
diencephalon, mid/hindbrain and eye tissues, thus making them heterogeneous and 
difficult to study and interpret with high confidence the exclusive nature of cortical 
stem cell fates in disease and health. Finally, the reduced variance in neuronal 
marker distribution in organoids derived by combined inhibition provides an 
additional discriminative evidence for improved cortical layer organization – a sign for 
the highly ordered generation of cortical building blocks. These differences could be 
enabled due to the systematic comparison of several methods performed in parallel, 
using different culture configurations, testing a number of developmental stages, and 
further supporting results with an analogous comparison in a disease model. To the 
best of our knowledge, there has not been any comprehensive comparative study 
that tackles all these parameters in parallel. While naturally, most studies are 
inherently limited to one selected derivation method, which is usually sufficient to 
successfully recapitulate the relevant developmental process and extract related 
disease phenotype, our study encourages the extension of such experimental model 
systems to more than one derivation method. 
 
While marked differences in generation of cortical vs non-cortical fates was achieved 
by the different derivation methods, our study reveals that specification towards 
medial pallial fates was comparable regardless of the derivation method. The medial 
pallium is responsible for generation of the cortical hem – a central cortical organizer 
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that directs specification of hippocampal primordia. In addition, studies portray the 
cortical hem as potential center responsible for shaping the size and arealization of 
the cortex itself [201], although this has been debated [189, 202]. The finding that all 
methods are compatible for cortical hem formation (at least transcriptionally) 
suggests that it is indifferent to morphogen levels such as TGF and interestingly also 
WNT. More remarkably, the finding that the generation of this structure is not 
affected in microcephaly - also here regardless of derivation method - further argues 
that cortical hem formation is resilient also under severe abnormal developmental 
circumstances. Therefore, it is tempting to speculate that this novel observation may 
link early neural patterning with early evolution of cortical organizers. More broadly, 
one could assume how important organizers such as the hem, which ultimately 
develop into basic limbic structures such as the hippocampus, have evolved to retain 
indifference to genetic changes that alter dorsomedial cortical patterning during 
evolution. 
 
We show here that the generation of homogeneous cortical starting populations 
requires addition of WNT-i on top of dual SMAD-i. Dual SMAD-i alone has shown to 
be critical to enhance neural conversion in monolayers and here it is shown to 
enhance Notch activation in both monolayers and organoids, at the HES5::eGFP 
reporter expression level and at the molecular level, possibly by promoting 
neurulation [203] and brining major impediment to endodermal and mesodermal 
lineages [204-206]. However, enhanced Notch activation results also in elevated 
patterning towards posterior fates, in agreement with high HES5 expression in 
hindbrain structures as deduced from Allen Brain Atlas expression databases [171]. 
This suggests that neural cortical cultures derived in the absence of WNT inhibition 
exhibit insufficient restriction of neural axis elongation / mesoderm formation. The 
addition of WNT inhibition strongly restricts gastrulation at the outset, thus further 
reinforcing CNS fates. However, it also specifies the telencephalic/cortical domain, 
thus rectifying potential residual posterior fate outcomes generated during the 
acquisition of early CNS fates. Thus, it seems that in vitro, residual mesodermal 
dedifferentiation is correlated with posterior neural axis patterning, in agreement with 
reported neuromesodermal progenitors expressing neural and mesodermal markers, 
and which later develop into posterior neurons [207]. This is less the case for 
inhibition of WNT alone, which seems sufficient to drive specification towards cortical 
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progenitor starting populations in organoids, but not in monolayers, supporting the 
notion of a more robust neural induction mechanism in 3D systems. However, WNT-i 
alone could not convey robust vesicle expansion in organoids and ensure their 
endurance during long-term culture, demonstrating the critical role of dual SMAD 
inhibition in NSC fate specification and proliferation.  
 
This work shows that despite the prevalence of enhanced Notch activation under 
both dual SMAD and combined inhibition - reflecting high stemness, only when it 
overlaps with efficient radial organization; it essentially hallmarks transition towards 
cortical fates. Radial organization of early PSC derived neural progenitors into neural 
rosettes has been described in many studies since the first description by Zhang and 
colleagues [116]. We were the first to isolate rosette forming NSCs (R-NSCs) with 
anterior character from human ESCs and further shown that the rosette formation 
process depended on Notch activation [119]. Since then, we have been able to 
specifically correlate rosette formation capacity to Notch activation during cortical 
fate specification at the cellular, molecular and cytoarchitectural dynamics levels 
[127, 146, 147]. However, these studies also marked heterogeneity in rosette 
formation capacity and regional identity [146]. Here we show that radial organization 
capacity becomes superior under combined inhibition, where it also coincides with 
enhanced Notch activation – together serving as readout for efficient cortical 
specification.  
 
We propose that these readouts are linked to actual properties of cortical NSCs. 
First, radial organization ensures that neuroepithelial cells acquire strong apico-basal 
cell polarity that is critical for forming a contiguous epithelial lining of the ventricular 
zone and preserve its unique cytoarchitectural radial organization, which in turn 
allows proper interkinetic nuclear migration and cell division at apical sites. 
Enhanced stemness (Notch activation) is required conducting proper cell fate 
decisions that continue to produce stem cells that progress through the distinct 
stages during cortical development. While our data does not argue that radial 
organization capacity is exclusive to cortical progenitors, they do demonstrate that 
this capacity is always shared by efficiently derived early cortical neuroepithelial 
cells, while it devoid in posterior early neuroepithelial cells such as diencephalon and 
mid-hindbrain. We therefore propose that enhanced Notch activation and radial 
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organization can be assigned as robust hallmarks for corticogenesis, with an 
emphasis on its early stages – namely creating the starting population for 
corticogenesis. 
 
The fact that enhanced Notch activation could be induced in two cytoarchitectural 
contexts - radially organized under combined inhibition or non-radially organized 
under dual SMAD inhibition - argues that WNT inhibition ensures that the enhanced 
neural stem cell state (promoted by dual SMAD inhibition) specifically occurs in 
cortical starting populations. The presence of vesicles in microcephaly organoids 
exhibiting compromised neuroepithelial cell integrity, substantial cell death in vesicle 
areas where Notch activation coincided radial organization, and concordant loss in 
NSC and cortical marker gene expression – all correspond with a model by which 
combined inhibition is essential for exerting the microcephaly phenotypes and may 
indeed represent a meaningful pathophysiological component in disease etiology. 
Conversely, derivation of microcephaly organoids under dual SMAD-i also caused 
significant reduction in NSC genes, yet apoptosis was hardly present and reduction 
in posterior fate-specific gene expression was non-significant, suggesting that while 
stemness is affected in microcephaly in all brain regions, only in the cortex it is 
deleterious enough to cause dramatic cell loss. Thus, our data propose that it is 
imperative to run differentiation on both methods for adding important insights to 
understanding disease pathology.  
 
While the above findings propose that cells committed to cortical fates pursue the 
apoptotic pathway, while those taking a non-cortical cell fate survive, one could not 
rule out the possibility that in addition to cortex specific cell death, defects in early 
neural patterning due to impaired WNT signaling for example, resulted in favored 
commitment towards posterior fates already at the outset of neural development. 
This is supported by the increase in posterior gene expression signature in day 17 
microcephaly organoids. However, on day 30, microcephaly organoids did not show 
this preferential expression, suggesting that most of the loss in cortical identity was 
due to cell death. 
 
Mechanistically, the smaller vesicle size, decrease in proliferation vs. differentiation 
index during early stages, and the cell cycle arrest at apical sites postulate a disease 
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model in which centrosome defects cause abnormal cell cycle checkpoint signaling 
during G2-to-M transition, consequent premature mitotic entry or mitotic arrest at 
apical sites, and eventual cell death [208, 209]. We were not able to record more 
asymmetrical cell divisions among P-VIM+ cells in microcephaly organoids and 
therefore our data could not argue at this point for depletion in stem cells due to 
increased asymmetric differentiation as mechanism that leads to premature 
consumption of NSCs. Rather, we propose cell cycle defects leading to cell death at 
the progenitor but presumably also during last division steps towards differentiation. 
Since cell death is surrounding Notch active radially organized regions, we propose 
that apical neural stem cells are primarily affected due to exhaust in cell proliferation, 
and this may be supported by findings that cerebral cortical ventricular zone 
progenitors have been shown to undergo some apoptosis in general [210]. It will be 
interesting to find out whether cortical progenitors are more prone to apoptosis due 
to increased cell cycle rates compared to posterior fates. This may also explain why 
cell death in microcephaly occurs primarily in a more active germinal zone, such as 
the cortical ventricular zone, despite the mutation being shared by all brain cells. 
There are several utilities for using Notch activation and radial organization as 
hallmarks or direct readouts for efficient early cortical specification. First, current 
readouts require assessment of cortical lamination after many days of differentiation 
(e.g. >100 days). Second, the use of markers that are less than optimal due to their 
appearance in other brain regions in vivo as well as under both inhibitory methods in 
organoids. Given the highly challenging task to compare differentiation efficiencies 
after 80 days in culture, either between different protocols, different lines, and 
different labs, our proposed readout specifically aids to standardize differentiation 
methods and predict overall cortical specification potential already at its early stages. 
In addition, these readouts may be used to predict the robustness of 
cytoarchitectural integrity (radial organization) and NSC potential (Notch activation), 
which so far have not been assessed during the various differentiation paradigms. 
 
Our work further harnesses the already established use of WNT signalling 
modulation in pluripotent, neural and non-neural lineages, to also standardize 
cortical differentiation systems. Ample evidence has been accumulated on WNT 
level modulation. WNT activation participates in maintaining a naïve ground state 
[169, 197, 199, 211-213], and promotes non-neural differentiation of primed 
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pluripotent cells [214, 215]. Reciprocally, WNT inhibition promotes priming of naïve 
PSCs towards epiblast stem cells [213], and is implicated in differentiation towards 
neural fates [216]. This equilibrium of WNT signaling in variety of pluripotent states 
[217] is reflected also in the nervous system. WNT activation is implicated in 
differentiation towards more posterior cell fates [207, 218], while WNT inhibition 
enhances anterior neural fates [118, 124-126, 133, 134, 136, 188]. Here we show 
that WNT inhibition is imperative for correct acquisition of cortical progenitor starting 
populations – which is a critical factor in preventing heterogeneity. Together with 
SMAD inhibition, enhanced NSC state is achieved in the correct progenitors, 
enabling the expansion and derivation of appropriate consecutive lineages. 
 
To conclude, we propose that the data generated in this study can serve as valuable 
and powerful references to model brain development and corticogenesis in 
particular, under normal and pathogenic conditions. The combined analyses of single 
organoid and human brain RNA-Seq datasets allow a unique platform for retrieval of 
critical information on how expression of stem cell, regional and other population-
specific genes is reflected by each of the derivation methods and with respect to all 
brain regions. This also provides a unique opportunity to transcriptionally compare 
between phenotypes and select the inhibition paradigm that fits clinically relevant 
cells. For the latter, one could also potentially simulate (in silico) or experiment 
several related diseases in parallel by different methods, opting out multiple 
phenotypes depending on treatment. The microcephaly expression profiles bring an 
additional in-platform, yet standalone data source that sheds light on this highly 
relevant malformation from which many potential developmental key players can be 
identified. The single cell dataset for organoids derived by combined inhibition 
provides a comprehensive in vivo-like snapshot reference of cellular identity 
composition in the embryonic cortex, particularly for identifying new genes expressed 
in well-established populations as well as identifying novel populations. Radial 
organization and Notch activation provide a robust readout for transition of PSCs 
towards early cortical neural stem cells. While Notch activation reporter is not 
naturally present in a lab toolbox, a very efficient radial organization serves quite 
robustly to score cultures transitioning to early cortical linages. Finally, the 
systematic comparison of organoids and monolayers derived by the different 
methods with respect to the transcriptional, cytoarchitectural and cell fates provides 
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another valuable tool to assess which among the 2D or 3D differentiation schemes is 
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A-P — Anterior-Posterior   
APC/C — Anaphase promoting complex / cyclosome 
AVE — Anterior visceral endoderm 
bHLH — Basic helix-loop-helix 
BMP — Bone morphogenetic protein 
bRG — Basal radial glial  
CC — Coiled coil 
CNS — Central nervous system 
CP — Cortical plate 
Dkk1 — Dickkopf 1 
D-V — Dorso-ventral 
EB — Embryoid body 
ESC — Embryonic stem cells 
FACS — Fluorescence activated cell sorting 
FGF — Fibroblast growth factor 
hESC — Human embryonic stem cells 
ICM — Inner cell mass 
INM — Interkinetic nuclear migration 
IP — Intermediate progenitors 
iPSC — Induced pluripotent stem cell 
MCPH — Microcephaly primary hereditary (Autosomal recessive primary 
microcephaly) 
MEF — Mouse embryonic fibroblast 
mESC — Mouse  embryonic stem cells 
mPSC — Mouse pluripotent stem cell 
NE — Neuroepithelial 
NECD — Notch extracellular domain 
NICD — Notch intra cellular domain 
NPC — Neural progenitor cell 
NSC — Neural stem cells 
OSVZ — Outer sub-ventricular zone 
140 
 
PSC — Pluripotent stem cells 
RA — Retinoic acid 
RG — Radial glial  
R-NSC — Rosette neural stem cell 
SHH — Sonic Hedgehog 
SVZ — Sub-ventricular zone 
TACE — TNF-α ADAM metalloprotease converting enzyme 
TE — Trophoectoderm 
TM — Transmembrane domain 
VZ — Ventricular zone 
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